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HEADING 1
INTRODUCTION
Many common ailments in equine related to performance or that reduce performance,
originate in the respiratory and musculoskeletal systems. The respiratory system is responsible
for proper ventilation and respiration, and the musculoskeletal system is responsible for muscle
contraction and locomotor movement both at rest and during exercise. While these two systems
appear to be highly developed, they are the source of common problems during performance that
will be further discussed in this paper. Within the respiratory system, inflammation is extremely
common, and can lead to more serious conditions such as recurrent airway obstruction and
exercise induced pulmonary hemorrhage (Mair et al., 2013; Couëtil et al., 2016). Within the
musculoskeletal system, there are varying levels of fatigue and exhaustion as well as lameness
(Marlin and Nankervis, 2002) which is considered by veterinarians as the number one cause of
issues in the performance horse. Since horses are considered “performance animals”, it is
extremely important to address and treat any conditions that lead to a reduction or inhibition of
performance.
Currently, there are conventional, regenerative, and alternative methods used to treat
common exercise related ailments. Conventional treatments consist of commonly used drugs and
medications but can generally not be used on a long-term basis due to well-known side-effects.
Nonsteroidal anti-inflammatory drugs, for example, possess great relieving properties, but can
also result in gastrointestinal ulcers due to their role in blocking gastrointestinal prostaglandins
(Dowling, 2002; Bland, 2015). To combat the issues with conventional treatments, regenerative
and alternative therapies have been developed in attempt to provide similar treatment of exercise
related issues with fewer side-effects. Stem cell therapy, physical therapies, nervous system
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stimulation, and supplementation of vitamins and minerals have all been evaluated and have
begun to be utilized by many horse owners. Fundamentally, it is necessary to understand how
exercise normally affects the equine respiratory and musculoskeletal systems to further
comprehend how these various treatments work to resolve the potential ailments and abnormal
responses.
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HEADING 2
EXERCISE
Any form of movement or activity being performed by the horse is considered exercise; if
they are moving from a resting position, work is being done (Marlin and Nankervis, 2002). For
exercise and muscle contraction to occur, the generation of ATP is required. Within the muscle,
there is a minimal store of ATP that can only maintain muscular contractions for up to a few
seconds (Hodgson et al., 2013). At the initiation of exercise creatine phosphate is broken down
into creatine and phosphate by the enzyme creatine kinase (CK) within the skeletal muscle,
producing a very rapid, yet very small amount of ATP (Reed et al., 2010a). Beyond this limited
time frame, there is an increased metabolic breakdown of fuel stores to meet the increased
demand for ATP (Hodgson et al., 2013). Metabolism can be broken down into two forms:
aerobic and anaerobic. Aerobic, or oxidative, metabolism primarily breaks down lipids in a slow,
energy-requiring process known as oxidative phosphorylation. Anaerobic metabolism primarily
breaks down carbohydrates, generally in the form of glucose, to lactic acid through the much
more rapid process of glycolysis. One of the primary differences between these two pathways is
that aerobic metabolism requires oxygen, whereas anaerobic metabolism can occur in the
absence of oxygen or when the oxygen supply is insufficient (Marlin and Nankervis, 2002;
Hodgson et al., 2013). The activation of each of these processes is dependent on the intensity and
duration of the exercise, and fundamentally the demand for energy at the level of the muscles
(Hodgson et al., 2013).
Intensity and Duration
Intensity is directly related to the speed of exercise (Hodgson et al., 2013) as well as the
level of effort required to undergo an activity (CDC, 2015). Duration is the total length of time
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the exercise is performed (Hodgson et al., 2013). Thoroughbred and quarter horse racing would
be examples of high intensity, short duration exercise; a large amount of work is exerted over a
short period of time utilizing anaerobic metabolism. Show training and competing in multiple
events within a single day would be an example of a medium intensity, medium duration
exercise; work is being performed but not necessarily to a level of fatigue, using a combination
of anaerobic and aerobic metabolism. Lastly, endurance racing would be an example of low
intensity, long duration exercise where aerobic metabolism is necessary to meet the high, longterm demand for energy (KER, 2002). High intensity exercises are necessary to improve strength
and anaerobic capacity, whereas low to medium intensities will lead to improvement in aerobic
capacity. The opposite is true for duration; long durations will lead to improvement in aerobic
capacity, and short durations, coupled with higher intensity, can improve strength and anaerobic
capacity (Hodgson et al., 2013). Comprehending theses different levels of performance that
horses undergo is critical to understand not only how their bodies will change and adapt but also
how physiological consequences can develop.
Responses to Exercise
During any increase in level of exercise and muscular activity, there is an increase in the
presence of exercise responses which help meet the short-term, physiological demands before
returning to normal levels (Marlin and Nankervis, 2002). Within the respiratory system,
increases in respiratory rate and the total volume of air being ventilated would be considered
exercise responses because they change during exercise and then return to normal levels once
exercise has ceased (Hodgson et al., 2013). Within the musculoskeletal system, increases in
lactic acid as a byproduct of metabolism would also be considered an exercise response (Marlin

5
and Nankervis, 2002). Any of these short-term exercise responses should return to their baseline
levels once the work is done.
Alternatively, conditioned responses, sometimes referred to as training responses, are
long-term adaptations to repeated bouts of muscular activity. As there is a gradual increase in the
amount of work being performed, the physiological systems will adapt to meet the increasing
demands (Marlin and Nankervis, 2002) and reduce the strain associated with increased amount
of stress placed on the body (Hinchcliff et al., 2007). Within the respiratory system, a noticeable
conditioned response is an increase the horse’s maximum oxygen uptake, allowing for a greater
delivery of oxygen to the muscles (Hodgson et al., 2013). Within the musculoskeletal system,
training has been observed to lead to an increased number of capillaries supplying the muscle
(Marlin and Nankervis, 2002), as well as more efficient removal of lactic acid produced from
metabolism (Hodgson et al., 2013).
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HEADING 3
RESPIRATORY SYSTEM
To fully understand physiological respiratory issues during exercise in equine, it is
necessary to have a comprehensive knowledge of the basic anatomy and its correlating
physiological responses perceived as normal. Some of these physiological responses include how
the circulation of blood interacts with the respiratory tract, the process of respiration and
ventilation, the normal amount of air inspired and expired, and frequency of breathing. In equine,
the most noticeable physiological changes to exercise within the respiratory system are shortterm physiological adaptations and adjustments the body makes during the stress of exercise but
generally return to what is considered normal at rest once the stress is removed. The respiratory
system of the horse has adapted tremendously for short term responses to exercise. Some of these
adaptations include large airways that allow for reduced resistance, energetically efficient
breathing, extreme lung capacity, large volumes of blood supplied to the lungs, as well as an
elongated respiratory system that strongly influences the air as it is inspired and expired (Marlin
and Nankervis, 2002). The primary exercise responses documented within the equine system
revolve around ventilation, perfusion, the ventilation perfusion interaction, respiratory-locomotor
coupling, thermoregulation, work of breathing, and intrathoracic pressures and forces. While
there are numerous short-term responses, the equine respiratory system is neither suited for longterm nor conditioned exercises responses, thus leading to physiological performance issues.
Anatomy
The respiratory system is divided into two sections: the upper and lower airways of the
respiratory tract. The primary function throughout the entire airway is to transport oxygen from
the external environment down to the level of the muscle through the process of gas exchange,
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where it is then utilized in the production of energy (Hodgson et al., 2013). The upper airway
consists of the nares, nasal cavities, soft palate, pharynx, larynx, trachea, bronchi, and alveolifree bronchioles (Hodgson et al., 2013). This portion of the airway is referred to as the
conducting zone, where no gas exchange occurs and the primary function is transportation of
gases from the external environment to the locations of gas exchange like water moving through
a pipe; it also warms, humidifies, and filters the air (Marlin and Nankervis, 2002; Raff and
Levitzky, 2011). The lower airway is comprised of the respiratory bronchioles, alveolar ducts
and alveolar sacs located within the lung. This portion of the airway is referred to as the
respiratory zone since its primary function is gas exchange.
Throughout the entire airway, nerves and muscles stimulate its functional capacities. At
the level of the lungs, the pulmonary and bronchial circulations function to transport diffused
oxygen to its necessary target locations (Raff and Levitzky, 2011; Hodgson et al., 2013).
The equine nares, or nostrils, are incredibly important features of the respiratory system.
The horse is known as an obligate nose breather, meaning it lacks the ability to inspire and expire
air through its mouth (Marlin and Nankervis, 2002; Hodgson et al., 2013). The horse relies solely
on the capabilities of the nares to trap and funnel the air into the respiratory tract. The extremely
large and mobile properties of the nostrils allow for expansion during the inspiratory process,
leading to flaring of the nares and then the subsequent collapse of the nasal diverticulum
(Hodgson et al., 2013). The large surface area of the nasal cavities not only provides a large
source for airflow resistance, but aids in the conducting zone functions of heat and water
exchange, warming and humidifying the air as it is transported (Hodgson et al., 2013). Increases
and decreases to airflow resistance in this portion of the airway can be controlled by
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vasoconstriction and vasodilation of the vasculature through both sympathetic and
parasympathetic innervation of nerve fibers (Hodgson et al., 2013).
The pharynx is divided into the nasopharynx and the oropharynx by the soft palate. The
opening of the soft palate is known as the intrapharyngeal ostium and articulates with the
conriculate cartilages and epiglottis of the larynx to form an airtight seal during breathing
(Hodgson et al., 2013). The function of the larynx is to channel the air flow from the nasal
passages down to the trachea, also aiding in the protection of the airway by closing during food
consumption (Hodgson et al., 2013; Shrauner, 2013). During ingestion, the laryngeal structures
adduct to form a tight seal, preventing food from entering the airway. During times such as
exercise, the laryngeal structures abduct and intrinsic muscles contract, creating maximal
opening of the larynx and decreased resistance to air flow (Hodgson et al., 2013). This specific
anatomy of the laryngeal structures creates a physiological limitation, rendering the horse
incapable of switching from nose breathing to mouth breathing during intense exercise as other
species are able to. The rima glottidis, the opening of the larynx into the trachea, is the narrowest
portion of the entire airway and if even partially obstructed can have a huge impact on airflow
and performance (Shrauner, 2013).
The equine trachea is a highly flexible but rigid tube approximately 70 to 80 centimeters
long, that extends from the larynx down to the lungs, including numerous dorsally open hyaline
cartilaginous rings that help to maintain its structure and prevent collapse in this portion of the
airway (Mair and Lane, 2005; Hodgson et al., 2013). The dorsal portion of the trachea is lined
with a layer of smooth muscle, the dorsal tracheal membrane, controlled via the autonomic
nervous system, that actually decreases tracheal compliance through smooth muscle contraction
(Mair and Lane, 2005; Hodgson et al., 2013). This decreased compliance unfortunately increases
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the possibility of collapse in the extra-thoracic portions of the trachea during forced inspiration,
such as during heavy exercise (Hodgson et al., 2013). Between the cartilaginous rings and
smooth muscle contraction it is almost an anatomical balancing act to maintain the opening of
this airway. As the trachea continues down towards the lungs, it branches into two principle
bronchi; termed the tracheal bifurcation (Hodgson et al., 2013). From this point, a series of
branching occurs from the principle bronchi into segmental bronchi, then bronchioles, and
ending at the terminal bronchioles (Hodgson et al., 2013). With each level of branching, there is
a decrease in individual radius, but an overall increase in surface area across the structure for
optimal levels of gas exchange (Raff and Levitzky, 2011).
The highly developed lung of the horse accounts for approximately 1% of the horses’
overall body weight; its large capacity plays an important factor in high intensity exercise
(Marlin and Nankervis, 2002; Hodgson et al., 2013). The left side of the lung can be divided into
the apical lobe, a diaphragmatic lobe, and an accessory lobe; the right side of the lung can be
divided into an apical lobe and a diaphragmatic lobe (Hodgson et al., 2013). The equine lung is
not separated by intra-lobular fissures such as in other mammals, but is conjoined via adhesion in
the mediastinum at its base (Sande and Tucker, 2004). The incomplete connective tissue septa
between the lobules of the equine lung permits the transfer of air from lobule to lobule via
accessory pathways (Marlin and Nankervis, 2002; Hodgson et al., 2013). This small amount of
collateral ventilation plays a compensatory role during the occurrence of obstructive diseases
(Hodgson et al., 2013), which will be discussed later on. While the lobules combine to form the
segments and lobes of the lung, they remain in a state of isolation, separated by their individual
broncho-vascular components (Sande and Tucker, 2004). Specifically in equine, the respiratory
bronchioles are not sufficient enough to participate in gas exchange, so primary gas exchange
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actually occurs further down in the lung at the level of the alveolarcapillaries (Hodgson et al.,
2013). The equine lung contains approximately 10 million alveoli with a large surface density
yet thin septa, and capillary numbers of more than 1000 times that (Hodgson et al., 2013).
There are three categories of muscles involved in respiration: inspiratory muscles,
expiratory muscles, and other muscles involved in respiration. The most well recognized muscle
involved in inspiration is the diaphragm which separates the abdomen and the thorax, and is
innervated by the phrenic nerve originating in the cervical spinal cord (Hinchcliff et al., 2007;
Hodgson et al., 2013). The other muscles involved in inspiration primarily serve to open and
close the rib cage in accordance with the expansion of the lungs (Hodgson et al., 2013). The
primary expiratory muscles are the abdominal muscles and the internal intercostal muscles which
contract to increase the pressure in the abdominal cavity and reduce thoracic volume as air is
expired (Hodgson et al., 2013). While contraction of these muscles is important, expiration relies
heavily on the relaxation of the diaphragm (Hinchcliff et al., 2007; Raff and Levitzky, 2011;
Hodgson et al., 2013). Some of the other muscles involved in respiration, such as the intrinsic
laryngeal muscles, aid in modification of the airway and are located further up at the level of the
nares, pharynx, and larynx (Hinchcliff et al., 2007; Hodgson et al., 2013).
Normal Physiological Responses
The relaxed volume of the respiratory system is identified as the equilibrium between the
inward recoil of the lung and the outward recoil of the chest wall. Most species, including
humans, breathe above or from this relaxed volume; the horse, however, breathes around this
relaxed volume. In humans, inhalation is an active process by which the diaphragm contracts,
and exhalation is a primarily passive process where the diaphragm relaxes (Raff and Levitzky,
2011). The horse is unique in that the second part of its exhalation is active, not passive, so
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energy is required for the contraction of the expiratory muscles. As the expiratory muscles
contract, abdominal pressure increases, and the relaxing diaphragm is forced forward which
reduces the thoracic volume (Hodgson et al., 2013). It has been hypothesized that the active
portion of exhalation and related passive portion of inhalation in equine results in a reduced work
of breathing, leading to a shared amount of work between the inspiratory and expiratory muscles
(Hodgson et al., 2013).
Ventilation is described by air moving in and out of the lungs, and can be quantifiably
measured (Marlin and Nankervis, 2002). The amount of air inspired and expired in each breath is
measured as tidal volume; generally around 12 milliliters per kilogram of body weight within the
resting horse (Hodgson et al., 2013). This measurement can be multiplied by the respiratory
frequency, approximately 14 breaths per min at rest, to estimate the total amount of air moved in
and out of the lung per minute; termed the minute ventilation averaging around 80 liters per
minute at rest (Marlin and Nankervis, 2002; Hodgson et al., 2013). Changes in minute ventilation
are subsequently due to changes either in tidal volume, respiratory frequency, or both. Within the
lung, there are areas known as dead space where gas exchange does not occur; for example in the
upper conducting airways (Marlin and Nankervis, 2002; Hodgson et al., 2013). This means that
only a portion of the minute ventilation reaches the level of the perfused alveoli within the lung
where gas exchange occurs. This amount of air actually participating in the process of gas
exchange from the lungs to the blood, or perfusion, is known as the alveolar ventilation. The
normal ventilation to perfusion ratio in equine is around 0.8 to 1 (Hodgson et al., 2013).
The interaction of the respiratory system and the circulatory system is dependent upon
the pulmonary and bronchial circulations. Through the pulmonary circulation, the pulmonary
artery carries deoxygenated venous blood from the right side of the heart to the capillaries in the
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lung at the level of the alveoli (Raff and Levitzky, 2011; Hodgson et al., 2013). It is here that the
oxygenated blood diffuses across the walls of the alveoli and is returned to the left side of the
heart via the pulmonary veins where it is further pumped throughout the body. The bronchial
circulation carries about 1-2% of the oxygenated blood that has just been brought to the left side
of the heart, and further supplies it to the airways and other structures within the lung (Hodgson
et al., 2013). In locations such as the trachea there is air moving through constantly, however,
nothing is actually diffusing across the membrane so oxygen must be supplied through
circulation (Raff and Levitzky, 2011).
Exercise Responses
Exercise has an extreme effect on respiratory frequency and tidal volume, subsequently
affecting the minute ventilation. It has been noted that with increases in speed there is a dramatic
increase in minute ventilation from the resting levels of 80-100 liters per minute to nearly 1800
liters per minute during strenuous exercise (Franklin et al., 2012; Hodgson et al., 2013). During
levels of submaximal exercise the increase in minute ventilation is relatively linear to the
increase in speed, relating to the demand for oxygen at the level of the muscles (Franklin et al.,
2012). At lower intensities of exercise such as a walk or trot, both increases in respiratory
frequency and tidal volume contribute to increased levels of minute ventilation, but at intensities
of exercise such as a canter the increase in minute ventilation is primarily due to the high
respiratory frequency (Hodgson et al., 2013). The increase in breathing frequency is also
described by a linear trend up to the level of a canter in the horse. Beyond this speed, increases
are still present but they prove to be minimal (Franklin et al., 2012). Once the horse reaches a
level of exercise relative to that of a gallop, the increase in minute ventilation is reliant on
independent increases in tidal volume. (Hodgson et al., 2013).
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The horse exhibits what is known as respiratory-locomotor coupling, where its
respiration and breathing frequency are correlated with its stride and movement (Marlin, 2015).
At a gallop this coupling sits at a tight 1:1 ratio of breathing frequency to stride. There have been
average reports of 110 to 130 step and respiratory frequencies per minute, with maximum reports
of 148 step and respiratory frequencies per minute (Hodgson et al., 2013). Because the
respiratory frequency is tightly coupled to stride frequency, its effect on minute ventilation at this
intensity of exercise is extremely limited. In fast galloping horses, increases in tidal volume from
12 to 15 liters have been reported, and this response is associated with the increased metabolic as
well as thermoregulatory demands (Jones, 1994; Hodgson et al., 2013). While the recovery time
of ventilation is dependent upon the intensity and duration of the exercise being performed, it is
possible for respiratory frequency to remain elevated for 30-60 minutes post exercise (Mair et al.,
2013).
Work of breathing increases dramatically during exercise due to increased expiratory
volume, inertial forces, elastic forces, and resistance. During exercise there is an increase in
intensity and blood flow resulting in increased flow acceleration through the trachea and other
airways (Franklin et al., 2012). Elastic forces are dependent on the recoil of the lung with the
chest wall and increase equally with the trans-pulmonary pressure. During high levels of
exercise, stiffness of the chest wall accompanied by a threefold increase in lung volume leads to
a significant increase in elastic work. Compulsory nasal breathing during exercise increases total
pulmonary resistance fundamentally increasing the resistive work. Increases in inertial, elastic,
and resistive work during exercise creates overall limitation for further increases in ventilation
(Hodgson et al., 2013).
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Conditioned Responses
The long-term training or condition responses are extremely minimal in equine compared
to the short-term exercise responses. The most noticeable training response in the horse is a rapid
and significant improvement in VO2 max, or the horse’s maximum oxygen uptake. This increase
in aerobic capacity is related to increases in cardiac output and oxygen consumption at the level
of the muscles (Hodgson et al., 2013). This increase in maximal oxygen uptake is relatively
modest at about 10-15% because the horse possesses the unique physiological capability of
splenic contraction, where it is able to actually contract its spleen during exercise to increase its
total red blood cell volume from approximately 40% at rest to 60% by the end of the exercise
period, fundamentally increasing the amount of oxygen carried to the muscles (Hodgson et al.,
2013; Marlin, 2015). Increases in the number of red blood cells released into circulation from the
spleen has been observed to be related to increases in sympathetic nervous system activity,
resulting from increases in overall exercise intensity (Wickler and Anderson, 2000; Hodgson et
al., 2013). So, the extent of this response may differ across disciplines. Red blood cells
concentrations have been observed to return to baseline levels within 1 hour post exercise in
reining Quarter Horses, concluding that splenic contraction itself is an exercise response
(Vazzana et al., 2014).
Knowledge of ventilation responses in the horse is limited to short-term responses.
Ventilation in the horse is only capable of very limited adaptations to training; there is very
minimal evidence relating to the effects of training on the ventilation response to exercise.
Previous studies observed that training did not significantly alter minute ventilation, respiratory
frequency, and tidal volume (Roberts et al., 1999). It has been hypothesized that during exercise
the relative energy cost of ventilation is reduced and the fatigue of the respiratory muscles is
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delayed (Hodgson et al., 2013). Hiraga and Sugano (2016) observed a reduction in overall
respiratory frequency as a result of training and suggested this might be the result of
improvements in cardiovascular function (Hiraga and Sugano, 2016). Potential increases in
inspiratory muscle strength from training could lead to increases in ventilation as a result of
reduced dead space and increased tidal volume (Marlin, 2015), but these are all assumptions that
have yet to be proven.
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HEADING 4
MUSCULOSKELETAL SYSTEM
The structure and function of the equine musculoskeletal system is the backbone of
locomotion in the exercising horse and is responsible for the horse’s extreme capabilities of both
high speed and endurance movement. Unlike the respiratory system, training responses are much
more prevalent in the equine musculoskeletal system than short-term exercise responses. The
extent of the skeletal muscle adaptations depends on the frequency, intensity, and duration of the
exercise conditioning program (Hodgson et al., 2013). The primary adaptations occur with the
proportion of fiber types, capillarization to the muscle, oxidative capacity, energy utilization and
stores, and muscle enzymes. To understand these adaptations, it is important to be familiar with
the individual components that comprise the gross anatomy of the muscle, and the stimulation
and processes that lead to muscle contraction.
Anatomy
Muscle bundles are comprised of hundreds of elongated, spindle-shaped muscle fibers or
cells (Marlin and Nankervis, 2002; Valberg and Macleay, 2015). It is within the muscle fiber that
force is generated through contraction (Hodgson et al., 2013). Muscle fibers are divided into
identifiable groups based upon their speed of contraction, oxidative capacities, energy utilization,
and diameter (Marlin and Nankervis, 2002; Hodgson et al., 2013; Valberg and Macleay, 2015).
An extensive network of capillaries and nerves branch throughout layers of thin sheets of
connective tissue surrounding the muscle fibers, to nourish as well as communicate with the
muscle fibers (Marlin and Nankervis, 2002; Valberg and Macleay, 2015). At the specialized
location of the motor end plate on the muscle cell membrane, motor neurons innervate the cells
(Hodgson et al., 2013). This system of nerves and muscle fibers is termed the motor unit
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(Valberg and Macleay, 2015). The muscle fiber itself is a system comprised of contractile
proteins such as actin and myosin, a basement membrane, and internal structures to which
neuromuscular stimulation occurs. Muscle fibers are strategically arranged within the muscle for
maximum power and efficiency during contraction and locomotion (Hodgson et al., 2013).
Numerous myofibrils pack together to form the striated structure of the muscle fiber (Raff and
Levitzky, 2011). It is within these myofibrils that the myofilaments, actin and myosin, are
aligned in an overlapping parallel formation to form the smallest functional unit of the muscle
cell, the sarcomere (Raff and Levitzky, 2011; Hodgson et al., 2013; Valberg and Macleay, 2015).
The polygonal shape of the myofibril has been measured between 1 to 3 micrometers in
diameter, with the total number of myofibrils present in each muscle fiber varying dependent
upon the muscle fiber’s overall contractile function and total cross-sectional area (Hodgson et al.,
2013).
The sarcomere, comprised of the thick and thin myofilaments, serves as the fundamental
unit of contraction (Hodgson et al., 2013). There is a parallel alignment of the thick filament,
myosin, and the thin filament, actin, that slide over each other and contract the muscle when
proper stimulation occurs (Raff and Levitzky, 2011; Hodgson et al., 2013). The Z-line of the
sarcomere is the end of the unit acting as a border between one sarcomere and another (Raff and
Levitzky, 2011). The I-band of the sarcomere is the portion of the thin acting filament where it
does not overlap with myosin (Hodgson et al., 2013). It extends from the Z-line to the center of
the sarcomere; the contractile proteins troponin and tropomyosin are also present within this area
(Marlin and Nankervis, 2002; Raff and Levitzky, 2011). The A-band is centrally located within
the sarcomere and is considered the full length of the myosin thick filament, including the
overlap with the actin thin filament. The H-band is the central region of the A-band consisting of
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only myosin thick filament; no overlap of myosin and actin (Marlin and Nankervis, 2002;
Hodgson et al., 2013). During contraction, the Z-lines move closer together, as the actin filament
is pulled over the myosin filament, causing the I-band to shorten while the A-band remains the
same length. The degree to which the myofilaments overlap plays an important role in the force
of contraction within each muscle fiber (Raff and Levitzky, 2011).
Thick myofilaments are primarily composed of myosin protein. Two heavy chains of
myosin spiral to form a double helix with long stable tails at their ends (Amory et al., 2010;
Hodgson et al., 2013). At the opposite end are globular heads containing both actin and ATP
binding sites (Hodgson et al., 2013). Actin is the primary protein within the composition of the
thin myofilament (Marlin and Nankervis, 2002). Two strands of actin twist into a double helix to
form the thin myofilament complex, containing binding sites for the myosin globular heads
(Hodgson et al., 2013). The protein tropomyosin spirals the actin helix, covering the myosin
binding sites. Bound to tropomyosin is troponin which contains three subunits: TN-T, TN-I, and
TN-C, each with their specific physiological function. TN-T attaches to tropomyosin, TN-I
inhibits the interaction between actin and myosin, and TN-C is the calcium binding component
which removes the inhibitory effects of TN-I in the presence of calcium (Raff and Levitzky,
2011; Hodgson et al., 2013). With a release of calcium, the inhibitory effects of the troponin
protein is removed, uncovering the binding sites, allowing myosin and actin to bind, and muscle
contraction to occur (Marlin and Nankervis, 2002).
The plasma membrane of muscle cell fibers, the sarcolemma, serves to maintain the
skeletal muscle structure while actively transporting substrates within the muscle cell (Marlin
and Nankervis, 2002; Campbell and Stull, 2003; Hodgson et al., 2013). It is also directly
involved in the excitation-contraction coupling process, transmitting the neural excitatory pulses
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involved with the physiological steps of muscle contraction (Campbell and Stull, 2003; Hodgson
et al., 2013). A lipid bilayer allows for the regulation and conductance of ions such as sodium,
potassium, and calcium through conducting pathways and ligand-gated ion channels that span
the membrane (Hodgson et al., 2013). Tubular invaginations, t-tubules, traverse across the
myofibrils and penetrate deep into the muscle fiber (Marlin and Nankervis, 2002; Hodgson et al.,
2013). Voltage gated ion channels contained within the t-tubules transmit electrical impulses
through the muscle fiber aiding in the contraction process (Hodgson et al., 2013). The basal
lamina of the skeletal muscle basement membrane serves as a direct link to the sarcolemma.
Protein structures within the basement membrane act as mechanical barriers, protecting the
sarcolemma from damage during muscle contraction (Campbell and Stull, 2003; Hodgson et al.,
2013).
In order for contraction to take place, there has to be a connection between the nervous
system and the muscle where stimulation and signaling can occur. The neuromuscular junction is
the axon terminal resting point on the motor neuron, and is the fundamental site of
communication between the nerves and the muscle fibers they supply (Hong and Etherington,
2011; Hodgson et al., 2013). Skeletal muscle is voluntary, requiring stimulation from the central
nervous system (CNS) for muscle contraction (Raff and Levitzky, 2011). Action potentials travel
down the axon in the direction of the skeletal muscle fibers, triggering motor neurons to
innervate the muscle at the neuromuscular junction (Raff and Levitzky, 2011; Hodgson et al.,
2013). This depolarization stimulates the release of the chemical neurotransmitter acetylcholine
from the presynaptic axon terminal, which then diffuses across the synaptic cleft where it binds
to its receptor on the sarcolemma. An influx of sodium ions into the cell results in another
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depolarization, an end plate potential, on the postsynaptic sarcolemma (Raff and Levitzky, 2011;
Hodgson et al., 2013).
Activation of voltage-gated sodium channels extends yet another wave of depolarization,
this time through the t-tubules into an intracellular membrane system of the muscle fiber, the
sarcoplasmic reticulum (Raff and Levitzky, 2011; Hodgson et al., 2013). This convoluted
membrane structure branches, forming a network surrounding each myofibril while remaining
physically separate from the sarcolemma (Rossi et al., 2008; Hodgson et al., 2013). The primary
role of the sarcoplasmic reticulum is feedback control regulating calcium homeostasis within the
skeletal muscle (Rossi and Dirksen, 2006; Rossi et al., 2008). High concentrations of calcium
binding proteins (i.e. calsequestrin), ryanodine receptors, and calcium ATPase are present in the
membrane of the sarcoplasmic reticulum (Rossi and Dirksen, 2006; Hodgson et al., 2013).
Activation of the dihydropyridine receptors (DHPR) on the muscle cell membrane cause the
ryanodine receptors in the sarcoplasmic reticulum to open (Raff and Levitzky, 2011; Hodgson et
al., 2013). The calcium required for skeletal muscle contraction diffuses solely from the
sarcoplasmic reticulum through the ryanodine receptors (calcium release channels) and into the
cytosol (Rossi and Dirksen, 2006; Raff and Levitzky, 2011). The release of calcium is
monitored strictly through the DHPR voltage sensors; if the voltage sensors are no longer
activated, release of calcium is rapidly stopped (Lamb, 2000).
Once calcium levels have reached a certain threshold, they are able to bind to the TN-C,
removing the inhibitory effects of the TN-I subunit on the troponin protein. This series of events
beginning with depolarization of the motor neuron ending with the mechanical shortening of the
muscle fibers is a process described as excitation-contraction coupling; the excitation of the
muscle followed by the contraction of the muscle (Marlin and Nankervis, 2002; Raff and
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Levitzky, 2011; Hodgson et al., 2013). When the inhibitory effects of the TN-I subunit are
removed, tropomyosin is pulled from the actin, exposing the myosin binding sites on the actin
protein (Hodgson et al., 2013). The myosin cross bridges are physically able to bind, pulling the
actin towards the center of the sarcomere (Marlin and Nankervis, 2002; Hodgson et al., 2013).
The sarcomere is shortened through contraction in a ratchet like fashion (Marlin and Nankervis,
2002; Hodgson et al., 2013). Calcium is actively transported from the cytosol back into the
sarcoplasmic reticulum via calcium ATPase. As calcium is removed from the cytosol and no
longer bound to tropomyosin, tropomyosin returns to its original position covering the myosin
binding sites on the actin thin filament, and relaxation of the myofibrils occurs (Marlin and
Nankervis, 2002; Raff and Levitzky, 2011; Hodgson et al., 2013). Relaxation of the muscle
requires energy in the form of ATP, making it an active process (Valberg and Macleay, 2015).
Fiber Types
There are three types of muscles fibers within equine skeletal muscle: type I, type IIA,
and type IIB. These categories differentiate based on oxidative capacity, glycolytic capacity,
size, energy utilization, speed of contraction, mitochondrial content, color, onset of fatigue, and
force of contraction (Raff and Levitzky, 2011; Hodgson et al., 2013). The presence of each type
of fiber varies between specific muscle groups, breeds, and individual horses (Valberg and
Macleay, 2015). Currently in horses, the contractile properties as well as the oxidative capacity
of the muscle fiber are primarily used for their classifications (Hodgson et al., 2013). The types
of muscle fibers are recruited or stimulated to contract based on the speed, duration, and intensity
of the exercise performed. During slow exercise, such as a walk or trot, type I fibers primarily
along with some type IIA fibers are recruited (Valberg and Macleay, 2015). As the speed
increases recruitment of type II fibers increases with type IIB fiber recruitment during near
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maximal exercise, when extremely forceful contractions are required (Hodgson et al., 2013;
Valberg and Macleay, 2015).
Type I are classified as red endurance or slow twitch-low oxidative fibers (Marlin and
Nankervis, 2002; Hodgson et al., 2013). They possess the greatest oxidative, aerobic capacity of
the three as well as the lowest glycolytic, anaerobic capacity (Raff and Levitzky, 2011). High
oxidative capacity is due to abundant amounts of mitochondria which are essential for aerobic
metabolism, and also give type I fibers their red color (Raff and Levitzky, 2011; Valberg and
Macleay, 2015). Since their primary role is aerobic metabolism, they have the highest resistance
to fatigue allowing them to contract the slowest and for the longest periods of time (Marlin and
Nankervis, 2002; Hodgson et al., 2013; Valberg and Macleay, 2015). They have the greatest
capillarization and blood flow, but the smallest diameter and weakest force of contraction of the
three types because they are not used for rapid and quick movements (Raff and Levitzky, 2011;
Hodgson et al., 2013). High lipid stores and low glycogen stores correlate with type I aerobic and
anaerobic capacities (Valberg and Macleay, 2015). Higher percentages as well as larger
diameters of type I fibers have been recorded in horses undergoing endurance performance
training (Rivero et al., 1993).
Type IIA are classified as intermediate or fast twitch-high oxidative fibers (Raff and
Levitzky, 2011; Hodgson et al., 2013). They possess moderate oxidative and glycolytic
capacities, with a fast force and speed of contraction (Marlin and Nankervis, 2002). They have
intermediate amounts of mitochondria, and are red in color similar to the type I fibers (Raff and
Levitzky, 2011). While they have a high glycogen content, they have low levels of lipids
correlating with their role in rapid movement (Marlin and Nankervis, 2002). Resistance to
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fatigue, diameter, capillarization are at intermediate levels compared to type I and type IIB fibers
(Raff and Levitzky, 2011; Valberg and Macleay, 2015).
Type IIB are classified as white sprint or fast twitch-low oxidative fibers (Marlin and
Nankervis, 2002; Hodgson et al., 2013). They have high glycolytic capacity with low oxidative
capacity, so they also have an abundance of glycogen and low lipid content for energy utilization
in anaerobic metabolism. They have the largest diameter, force, and speed of contraction;
diameter of the fiber is generally proportional to its force of contraction (Valberg and Macleay,
2015). They are white in color due to their extremely few number of mitochondria and have a
very low level of capillarization as well as resistance to fatigue. Type IIB fibers are the power
fibers of the muscle, primarily used for forceful rapid movement such as a sprint or race.
Endurance performance horses showed lower percentages of type IIB fibers (Rivero et al., 1993),
and racing horses such as Thoroughbreds showed extremely high percentages of type IIB fibers
compared to type I and type IIA (Valberg and Macleay, 2015).
Exercise Responses
One of the primary responses to exercise within the musculoskeletal system is an increase
in body temperature. Heat is a byproduct of metabolism, so as metabolism increases so does the
amount of heat circulating within the body (Hodgson et al., 2013). It has been noted that the
greatest increase in temperature during exercise compared to normal levels in equine occurs at
the level of the muscle (Hodgson et al., 1993). Along with heat, lactate production increases with
increased metabolism (Hodgson et al., 2013). Lactate accumulation occurs at all intensities of
exercise, but is primarily a byproduct of anaerobic metabolism within type II muscle fibers at
high intensity exercise (Hodgson et al., 2013; Valberg and Macleay, 2015) As lactic acid
increases at a rate proportionally faster than it can be removed from muscle, it moves down and
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out of the cell circulating throughout the body (Marlin and Nankervis, 2002). Increases in lactate
leads to decreases in pH, causing increased acidity within the blood and muscle. Both dramatic
increases in temperature and the onset of blood lactate accumulation at concentrations of 4
mmol/L are contributing factors to the onset of fatigue, which impairs exercise performance
(Hodgson et al., 2013).
The occurrence of aerobic and anaerobic metabolism within the muscle is dependent on
the intensity of the exercise. Aerobic metabolism will occur until the horse reaches its VO2max,
maximum oxygen consumption; it then must resort to anaerobic metabolism to meet the energy
demands of the muscle (Valberg and Macleay, 2015). During low intensity exercise when type I
and type IIA muscle fibers are recruited, aerobic metabolism primarily takes place using stored
fatty acids along with a small amount of anaerobic metabolism using some of the glycogen stores
(Marlin and Nankervis, 2002). Moderate intensities of exercise utilize both fatty acid and
glycogen stores for aerobic metabolism, and can lead to a depletion of glycogen stores (Valberg
and Macleay, 2015); however, due to the large quantity of fatty acids stored, depletion is unlikely
(Marlin and Nankervis, 2002). At high intensity exercise, duration is the primary determinant of
whether metabolism is aerobic or anaerobic. There is a high chance of glycogen store depletion
as well as an increase in plasma potassium concentrations with increasing exercise intensity
(Marlin and Nankervis, 2002; Hodgson et al., 2013). Upon the completion of exercise, plasma
potassium is rapidly taken back up into the muscle (Hodgson et al., 2013).
Conditioned Responses
There is an increase in the amount of type IIA and a decrease in type IIB muscle fibers
after a conditioning program. Studies have shown that short-term training in racehorses elicits a
hypertrophic response, so an increase in the size of the actual muscle fibers (Rivero et al., 2007),
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whereas in a long-term conditioning program, the diameter of the type IIB fibers decreases. For
both endurance and speed training, a decrease in the number and diameter of type IIB fibers was
recorded (Valberg and Macleay, 2015). Along with an increase in muscle fibers, there is an
increased number of capillaries supplying the skeletal muscle, increasing surface area at the
muscle for greater perfusion of blood (Marlin and Nankervis, 2002). The increase in
capillarization along with the decrease in the size of the muscle fibers results in a more direct
delivery of oxygen to the muscle fibers, and aids in more efficient removal of metabolic
byproducts such as heat and lactate (Hodgson et al., 2013). Studies have shown that duration
rather than intensity of exercise produces the greatest effect on these factors (Rivero et al., 2007).
The gradual increase in type IIA muscle fibers and capillarization accompanied by an
increase in mitochondrial density and oxidative enzymes increases the oxidative capacity of the
muscle (Lindholm, 1986; Hodgson et al., 2013). Development of new mitochondria has been
recorded as an adaptation primarily during endurance training (Rivero et al., 2007). The muscle
now has an increased capacity to utilize oxygen for aerobic metabolism, so the utilization of
anaerobic metabolism decreases. Since lactate is primarily a byproduct of anaerobic metabolism,
the onset of blood lactate accumulation is delayed, fundamentally delaying the onset of fatigue at
the level of the muscle (Lindholm, 1986; Marlin and Nankervis, 2002). With a shift from
anaerobic to aerobic metabolism, there is also a transition in the utilization of fuel stores. The
muscle gains an increased capacity to utilize fat as a fuel source with an increased aerobic
capacity, leading to increased efficiency of energy production. There is also a notable increase in
the glycogen content utilized for either type of metabolism, aiding in the prevention of glycogen
store depletion, further delaying the onset of fatigue (Marlin and Nankervis, 2002). Overall,
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these long-term adaptations allow the horse to perform at increased intensities for increased
amounts of time.
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HEADING 5
INFLAMMATORY PROCESS
Inflammation is the body’s principle response to injuries including swelling, redness,
fever and pain. There are short-term and long-term adaptive responses to inflammation that occur
when a tissue signals cells to respond to damage (Hotamisligil, 2006). So, even incredibly minor
tissue damage, for instance to the skeletal muscles during exercise, can trigger an inflammatory
response; strenuous exercise has been observed to induce a pro-inflammatory state in equine
(Donovan et al., 2007). While the acute inflammatory response during exercise is essential for
the musculoskeletal healing and repair process, chronic inflammation can lead to muscle damage
that drastically impairs the horse’s performance (Horohov et al., 2012). As a direct result of any
tissue damage or irritation, phospholipase A2 is activated and cleaves arachidonic acid from the
damaged phospholipid cell wall (Dowling, 2002). Arachidonic acid further activates the
cyclooxygenase (COX) I, COX II, and lipoxygenase enzymes. These enzymes are responsible
for prostaglandin and leukotriene production, which directly lead to pain, inflammation, and
bronchoconstriction (Kidd and Urban, 2001). Currently in medicine, treatments and therapies
aim to disrupt this pathway in attempts to reduce pain and inflammation, which will be discussed
later on.
One of the key components of the inflammatory process is the activation of
inflammation-associated pain. Nociception is the “detection of noxious stimuli and the
subsequent transmission of encoded information to the brain” (Kidd and Urban, 2001). So,
nociceptors are activated by any stimuli that could potentially be harmful, poisonous, or
unpleasant for the body and further signal the body to respond. When tissue becomes damaged,
there is a triggered release of inflammatory mediators which act both directly and indirectly on
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the nociceptors. Peripheral nociceptors are directly activated by some of the inflammatory
mediators, such as the prostaglandins synthesized by the COX I and II enzymes, resulting in the
spontaneous pain associated with inflammation. Other inflammatory mediators, however,
stimulate release of pain-inducing agents, such as pro-inflammatory cytokines, activating the
nociceptors indirectly (Kidd and Urban, 2001).
The fundamental goal of this pain and inflammation is to signal the body and immune
system to respond and repair. Neutrophils, which make up approximately 50% of the total
circulating white blood cells (WBC) (Delves, 2017) and 5% of bronchoalveolar lavage (BAL)
fluid cells (Couëtil et al., 2016), are the first type of immune cells to travel to the target site and
can produce lipids, cytokines, proteases, and other products that can all play a role in the
inflammatory process (Sampson, 2000). Cytokines work to mediate cell to cell interactions and
enhance the effects of immune cells (Kidd and Urban, 2001). Neutrophils eventually undergo
apoptosis followed by phagocytosis; this causes macrophages to switch from producing proinflammatory cytokines to production of prostaglandins and proteins involved in postinflammatory repair (Sampson, 2000).
Some of the primary pro-inflammatory cytokines observed in the equine inflammatory
process are tumor necrosis factor- (TNF-), interleukin-1 (IL-1), and interleukin-6 (IL-6).
TNF- plays a key role in regulation of immune cells, IL-1 mediates responses to both
infection and injury, and IL-6 works to increase acute phase protein production (Reed et al.,
2010c). Horohov et al. (2012) observed that racing-type exercise is associated with a significant,
intensity-dependent expression of TNF- and IL-1 roughly two hours after the exercise period,
with no significant changes in IL-6 expression. It was observed that training resulted in an
increased expression of IL-6 with a reduction in the expression TNF- and IL-1 compared to
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pre-training levels; it was theorized that upregulation of IL-6 actually reduces pro-inflammatory
TNF- and IL-1 expression (Horohov et al., 2012).
Along with phagocytic neutrophils, eosinophils are a key WBC that primarily increase in
concentration in response to hyperresponsive reactions (Mair et al., 2013), such as Inflammatory
Airway Disease (IAD) (Mazan et al., 2014). Eosinophils aid in the inflammatory-immune
process through degradation of inflammatory mediators, such as leukotrienes, and subsequently
modulating immediate hypersensitivity (Mair et al., 2013; Liesveld and Reagan, 2016). Since
eosinophils primarily target organisms that are too large to undergo phagocytosis, they secrete
toxins and proteins responsible for organism degradation (Delves, 2017). Generally, eosinophils
constitute approximately 5% of the total circulating WBCs (Delves, 2017), but these baseline
concentrations have been observed to decline with increases in stress and plasma cortisol, as well
as corticosteroid administration (Liesveld and Reagan, 2016). Neutrophilia and eosinophilia are
both utilized in the diagnosis of airway inflammation (Sprayberry and Robinson, 2015), which
will be discussed further on.
Along with increased concentrations of WBCs, another common marker of inflammation
are acute phase proteins; proteins whose plasma concentrations increase or decrease by a
minimum of twenty-five percent during an inflammatory response. When any type of tissue
damage occurs, such as from oxidative stress during exercise, the system acute phase response
(APR) is triggered in attempts to minimize the damage from possible pathogens and restore the
body to homeostasis (Satue et al., 2013). Inflammatory cytokine production stimulates the
production and release of acute phase proteins such as C-reactive protein (CRP) and serum
amyloid A (SAA) (Gabay and Kushner, 1999).
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C-reactive protein is considered the “golden marker” of inflammation primarily in canine,
swine, and humans (Ramamoorthy et al., 2012). While CRP concentrations have been observed
in horses to increase in response to induced inflammation, arthritis, enteritis, and laminitis
(Cywińska et al., 2012), SAA is actually the major acute phase protein in the equine
inflammatory process (Satue et al., 2013). When tissues become damaged and inflamed,
cytokines are released from the site of injury and further synthesize SAA within the liver; when
tissue damage has ceased or been repaired, SAA is rapidly degraded within the liver. The rapid
synthesis of SAA, response to tissue damage, and subsequent degradation make it an accurate
marker of the real-time extent of inflammation and injury. Serum amyloid A can increase up to
1000 times its baseline level during the APR in proportion to the level of tissue damage. For
example, an increase from baseline concentrations of 1 mg/L APR to concentrations of 1000
mg/L can be indicative of poor conditioning in horses (Satue et al., 2013). A significant positive
correlation has been observed between SAA concentrations and WBC concentrations (Turlo et
al., 2015). A primary role of SAA is inhibition of neutrophil function (Reed et al., 2010c). As an
animal becomes more conditioned to exercise, this inflammatory response decreases and changes
in acute phase protein concentrations become less observable (Beckstett, 2012). It could be
theorized that changes become less observable due to increases in baseline levels of SAA, and
while neutrophil production may not be altered, there potentially is a greater inhibition of
neutrophil function from this increase in SAA, resulting in a reduced overall inflammatory
response.
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HEADING 6
COMMON AILMENTS IN THE EXERCISED HORSE
Fatigue
Fatigue is reached when the horse is no longer able to continue performing at a certain
intensity or level of exercise; the animal must either stop exercising, or continue at a lower
intensity (Hodgson et al., 2013). The onset of fatigue is primarily dictated by duration and
intensity of exercise, the horse’s physical condition, as well as environmental factors such as
temperature, humidity, and altitude. Causes of muscular fatigue include depletion and
impairment of muscle fuel stores, altered fluid and ion balances, impaired muscle fiber
recruitment, and hyperthermia. Fatigue occurs during both sub-maximal and maximal levels of
exercise as well as during aerobic and anaerobic production (Marlin and Nankervis, 2002;
Munsterman and Vaughan, 2015). There are two classifications of fatigue, central and peripheral.
Peripheral fatigue occurs primarily at the level of the muscle and relates to depletion of glycogen
and other fuel stores, decreased ATP production, decreased pH, increased blood lactate, and
other intermediates and byproducts of metabolism. Central fatigue involves neurological and
psychological processes at the level of the CNS primarily relating to frequency of action
potentials needed for muscle contraction. Pain, exertion, hyperthermia, and decreased blood
glucose are all probable causes of central fatigue and can result in decreased muscle
coordination, muscle tiredness, and motivation to perform (Munsterman and Vaughan, 2015) .
High intensity, maximal exercise can lead to rapid onset of fatigue in the horse due to
rapid depletion of high energy glycogen and phosphate stores and increase of anaerobic
metabolic byproducts such as lactate and heat, primarily within type IIB muscle fibers (Marlin
and Nankervis, 2002). Increases in lactate production cause decreases in muscle pH resulting in a
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more acidic environment which can reduce the respiratory capacity of the skeletal muscle and
impair the functional capacities of the sarcoplasmic reticulum (Hodgson et al., 2013).
Impairment of the sarcoplasmic reticulum leads to imbalances of calcium and potassium within
the muscle cell required for the contractile process (Munsterman and Vaughan, 2015).
The onset of fatigue, resulting from prolonged submaximal exercise, is relative to the
intensity and duration of the exercise performed. Fatigue will occur more rapidly in a horse
trotting for a thirty-minute period verses walking for a thirty-minute period. Submaximal
exercise fatigue is primarily a result of altered fluid and ion balances, depleted muscle glycogen
stores, and hyperthermia (Marlin and Nankervis, 2002; Hodgson et al., 2013). As previously
discussed, the horse sweats a tremendous amount during exercise to aid in thermoregulation.
This large amount of total body water loss, if not replaced, can result in dehydration as well as
imbalances in concentrations of electrolytes required for muscle contraction (Marlin and
Nankervis, 2002). Prolonged metabolism leads to depletion of muscle glycogen stores; it is likely
that the onset of fatigue precedes the exhaustion of lipid stores utilized for aerobic metabolism
(Munsterman and Vaughan, 2015).
Heat generation during prolonged exercise is elevated as a byproduct of increased aerobic
metabolism. High body temperatures can impair mitochondrial function decreasing capacity of
aerobic metabolism, resulting in greater thermoregulatory demands, and increased risk of
hyperthermia especially under hot and humid conditions (Marlin and Nankervis, 2002; Hodgson
et al., 2013). Blood flow is increased to aid in heat dissipation at the level of the skin, causing
blood flow to diverge away from the working muscle decreasing the exchange of oxygen, carbon
dioxide, and other metabolic byproducts (Hodgson et al., 2013).

33
Exhausted Horse Syndrome
The onset of fatigue during exercise is a normal process, and aids in the prevention of
structural damage that could occur if the horse continues exercising at that exercise intensity;
however, there are fatigue induced syndromes that require further attention and treatment.
Occasionally during both maximal and submaximal exercise intensities, horses can develop a
more severe form of fatigue known as exhausted horse syndrome (EHS) (Mair et al., 2013).
Water loss, increased heat generation from metabolism, electrolyte imbalances, and depletion of
energy stores like in normal fatigue are all causes of EHS but to a more severe extent (Mair et
al., 2013; Munsterman and Vaughan, 2015). Horses presenting with EHS may experience water
loss up to 10% of their total body weight primarily from high levels of sweating (Munsterman
and Vaughan, 2015). With that said, thirst is generally suppressed due to pain from small
intestinal distention caused by decreased intestinal mobility (ileus) (Mair et al., 2013). The
combination of increased water loss and decreased desire to consume water only increases the
severity of dehydration. Exhausted horse syndrome can also lead to further problems such as
colic and laminitis (Munsterman and Vaughan, 2015).
Low intensity events such as endurance training can lead to a metabolic alkalosis, or
increases in pH above normal due to losses of calcium (hypocalcemia) and magnesium
(hypomagnesia) through sweating (Munsterman and Vaughan, 2015). Depletion of calcium and
magnesium can also contribute to neuromuscular dysfunction and ileus (Valberg, 2016). When
the interaction between the nervous system and intestinal muscle is impaired, muscle contraction
in a portion of the gastrointestinal tract may stop but digestion itself continues. As microbes
continue to digest, gases are produced and trapped, leading to small intestinal distention. Fluids
will migrate from the blood to the intestine, further dehydrating the horse. A lack of intestinal
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muscle contraction can also result in a buildup of digesta, obstructing the gastrointestinal tract,
potentially inducing colic. If the obstruction occurs in the small intestine, distention and fluid
buildup can occur in the stomach, causing it to expand and potentially rupture (Piscopo, 2008).
On the other hand, during high intensity events and training such as 3-day eventing there
is risk for metabolic acidosis or decreases below normal values due to increased lactic acid as a
byproduct of anaerobic metabolism. There is usually the presence of metabolic alkalosis once the
acidosis subsides after exercise recovery (Munsterman and Vaughan, 2015). To compensate for a
metabolic acidosis, there is an increase in the respiratory frequency in attempts to reduce carbon
dioxide in the body (Mair et al., 2013). Overall, the acidosis will induce the onset of fatigue more
rapidly, and the alkalosis will impair nervous system, musculoskeletal system, and
gastrointestinal function.
Based on these physiological alterations, clinical signs include increased heart rate and
respiratory rate above normal even at rest, severe dehydration and concentrated or absent urine
due to excessive sweating, muscle spasms or cramps due to electrolyte imbalances, increased
body temperatures above normal, and gastrointestinal problems (Mair et al., 2013; Munsterman
and Vaughan, 2015). Common treatments for EHS include administration of isotonic fluids and
electrolytes intravenously or orally to aid in dehydration and electrolyte imbalances; cooling the
horse through cold hosing, shading, cold water sponge baths, and even cool-water enemas;
nonsteroidal anti-inflammatory drugs for muscle spasms, cramps, and pain once the horse is
rehydrated (Mair et al., 2013; Munsterman and Vaughan, 2015).
Heat Stroke
Horses possess a large body mass relative to body surface area limiting thermoregulation
and heat dissipation during exercise; coupled with exercise and training in hot and humid
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conditions, the risk for heat related illnesses is increased. Heat stroke clinically occurs when the
horse’s core body temperature increases above 40 degrees Celsius and is followed by abnormal
function of the CNS and the motor controls of the brain (Bouchama and Knochel, 2002; Mair et
al., 2013). Heat stroke can be classified either as classic, which occurs with hot and humid
environmental conditions in the absence of physical activity, or as exertional, which occurs with
strenuous exercise but not necessarily in hot and humid environments. Horses performing in hot
and humid environments typically experience uncompensable heat stress, where the environment
impairs their evaporative cooling capabilities, which further increases the risk for exertional heat
stroke (Leon and Bouchama, 2015).
The brain’s ability to aid in thermoregulation is partially impaired because of increases in
brain temperature during exercise, resulting in CNS abnormalities which can lead to loss of
motor coordination/control and impaired neuromuscular function; in severe cases convulsions,
coma, and death can occur (Lindinger, 1999; Bouchama and Knochel, 2002). In a study by
Bouchama and De Vol (2001) assessing the acid-base balance during heat stroke in humans,
metabolic acidosis was prevalent in 81% of patients. It was observed that the metabolic acidosis
was significantly associated with the presence of hyperthermia, and concluded that metabolic
acidosis is a predominant response to heat stroke (Bouchama and De Vol, 2001). Clinical signs
of heat stroke in the horse include increased heart and respiratory rates, increased body
temperatures of greater than 40 degrees Celsius, hot skin, depression, convulsions, disorientation,
collapsing, coma, and death (Bouchama and Knochel, 2002; Mair et al., 2013).
Treatments for heat stroke aid in reducing and controlling the core body temperature
which can be done through cold water baths and increased ventilation as well as restoring
hydration via intravenous fluid administration. Nonsteroidal anti-inflammatory drugs can be used
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for inflammation and pain management (Mair et al., 2013) once the horse has been properly
hydrated to avoid detrimental effects on kidney function (Orme, 1986). Paying attention and
treating the initial and less severe symptoms is as wise and preventative measure for coma and
death.
Exertional Rhabdomyolysis “Tying Up”
The most common exertional myopathy in equine is Exertional Rhabdomyolysis (ER),
which can be divided into two primary forms: sporadic, most common during rest after exercise,
and chronic, which is generally the result of genetic abnormalities and disorders (Anderson and
Chesworth, 2016). The term “rhabdomyolysis” describes skeletal muscle necrosis, which in this
case is a result of some level of exertion or exercise being performed by the horse (Valberg,
2016).
Susceptibility to Sporadic Exertional Rhabdomyolysis (SER) has been observed across
all breed lines in equine (Valberg, 2016). Commonly, SER results when the horse undergoes a
level of exercise that exceeds its current physiological state of training. Some of the contributing
factors increasing the risk of SER include strenuous exercise beyond the training level of the
horse, electrolyte imbalances, vitamin E and selenium deficiencies, high non-structural
carbohydrate diets, as well as heat stress and exhaustion as previously discussed (Mair et al.,
2013; Valberg, 2016). Non-structural carbohydrates consist of either simple sugars or possess the
ability to be broken down by endogenous enzymes; high grain diets would contain high amounts
of non-structural carbohydrates (Pagan, 1998). As previously discussed, lactic acid production
primarily occurs as a result of anaerobic metabolism (Marlin and Nankervis, 2002). If the horse
is exercising above its level of training, it is likely exceeding its VO2max, primarily generating
ATP through anaerobic metabolism, and rapidly increasing lactic acid production. This overall
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rapid build of lactic acid in the muscle causes the observed stiffness in gait, reluctance to move,
and early onset of fatigue in SER horses (Lindholm, 1986; Mair et al., 2013).
Chronic Exertional Rhabdomyolysis (CER) is defined as recurring episodes of
rhabdomyolysis that occur even with only light bouts of exercise; CER has been observed to be
caused by Recurrent Exertional Rhabdomyolysis (RER), Polysaccharide Storage Myopathy
(PSSM) Type I, and PSSM Type II (Valberg, 2016). Recurrent Exertional Rhabdomyolysis is
thought to be a result of abnormal intracellular calcium concentrations and regulation leading to
muscle spasms and cramping, with increases in incidences following certain breed lines of
horses. This genetic susceptibility has been primarily observed and studied in Standardbred and
Thoroughbred horses (Mair et al., 2013; Anderson and Chesworth, 2016). Polysaccharide
Storage Myopathy Type I occurs do to an inherited mutation of the glycogen synthase 1 (GYS1)
gene which causes a defect in glycogen metabolism; the underlying cause of PSSM Type II has
yet to be determined but has been observed to result in the similar abnormalities of glycogen
metabolism. In both type I and type II PSSM, glycogen is abnormally accumulated and stored.
Quarter horses, Draft horses, Warmblood breeds, and Light breeds have been observed to be
affected by PSSM (Mair et al., 2013; Valberg, 2016). During rest periods post exercise, generally
one to two days, there is a build-up of intracellular glycogen stores resulting in damage to the
muscle fibers during the following exercise period (Anderson and Chesworth, 2016). It has been
theorized that the build-up of intracellular glycogen stores increases lactate production resulting
in a skeletal muscle necrosis and subsequent metabolic acidosis. This acute metabolic acidosis
increases the production of inflammatory interleukins, while suppressing WBC function;
fundamentally it stimulates the inflammatory response, while simultaneously impairing the
immune response (Kraut and Madias, 2010).
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While PSSM is one type of glycogenosis, a disease characterized by abnormal storage of
glycogen in tissues (DiMauro and Lamperti, 2001), which can result in rhabdomyolysis during
both rest and exertion, Glycogen Branching Enzyme Deficiency (GBED) is another reported
glycogenosis in equine (DiMauro and Lamperti, 2001; Ward et al., 2004). Glycogen Branching
Enzyme Deficiency is a result of an inherited nonsense mutation in the equine Glycogen
Branching Enzyme (GBE1) gene which subsequently causes accumulation of poorly branched
glycogen within the tissues (Ward et al., 2004). In comparison to PSSM, GBED is classified as a
non-exertional myopathy, so it has been observed to be associated with rhabdomyolysis but its
effects are not exacerbated by exertion; this condition can be fatal in foals (Aleman, 2008).
Araujo et al. (2018) observed that the prevalence of testing heterozygous for the GBE1 mutation
in 742 Quarter Horses was 7.95%, and prevalence was highest in cutting horses with no carriers
detected in racing horses (Araujo et al., 2018).
Clinical signs of ER include abnormal, stiff, or halted gait; noticeable pain in the hind
end often within 20 minutes of exercise; reluctance to move; increased heart rate, respiratory
rate, core body temperature, and sweating; immobility in severe cases. Symptoms are variable
dependent on severity of the disorder. (Lindholm, 1986; Mair et al., 2013). In severe cases of ER,
both sporadic and chronic, there is also an increased risk of renal failure. As the skeletal muscle
is degraded, myoglobin, creatine kinase (CK), and aspartate aminotransferase (AST) are released
from the muscle into the blood stream. These muscle proteins end up precipitating in the kidney
and impairing renal function (Clarkson, 2007). Increases in myoglobin within the urine can cause
pigmenturia, or the urine to appear dark red in color (Reed et al., 2010a). High concentrations of
muscle proteins within the kidney can also lead to significant increases in concentrations of urea,
which can be an indication of renal failure (el-Ashker, 2011). Observance of clinical signs can
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aid in diagnosis, along with elevated post-exercise levels of CK, AST, and lactate dehydrogenase
in serum compared to pre-exercise (Mair et al., 2013; Anderson and Chesworth, 2016).
Dehydration along with electrolyte imbalances such as low chloride and calcium concentrations
are also possible ER indicators (Mair et al., 2013).
Identifying the specific type of exertional myopathy occurring is important in
implementation of a treatment program. General treatment of ER includes rest periods for a
minimum of 48 hours with increases in time dependent on severity of disorder, sometimes for
weeks; fluid and electrolyte therapy to correct imbalances; anti-inflammatories, corticosteroids,
and muscle relaxants; adjustments to a low carbohydrate, high fat diet specifically for horses
with PSSM and GBED-related ER. These adjustments in diet, fluid and electrolyte therapy, and
implementing rest periods can be preventative measures as well (Mair et al., 2013; Anderson and
Chesworth, 2016).
Inflammatory Airway Disease
This disorder is representative of inflammation primarily in the peripheral airway as a
result of excessive accumulation of mucus and inflammatory WBCs (Sprayberry and Robinson,
2015); the specific cause of this excessive accumulation in IAD is not fully understood (Reed et
al., 2010b). Inflammatory airway disease (IAD) is generally mild, but can increase the risk of
more severe respiratory problems (Couëtil et al., 2016). General inflammation in the airway can
be a response to primary issues such as bronchitis, airborne allergens, viral infections, as well as
blood from hemorrhage in the lower airway (Reed et al., 2010b; Mair et al., 2013). Airway
inflammation in IAD horses is usually a hyperresponsive reaction induced by environmental
factors such as dusty hay and bedding, or even just being stabled verses pastured can increase the
exposure to endotoxins resulting in neutrophilic inflammation; it has also been observed that low
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temperatures of inspired air increases neutrophil concentrations leading to IAD (Reed et al.,
2010b). Couëtil et al (2016) concluded in a revised consensus statement on IAD in horses that
there currently is no evidence of genetic susceptibility among breed lines, and that horses from
all ages, breeds, and disciplines can develop IAD (Couëtil et al., 2016). While IAD has been
observed across all ages, it is most commonly reported in young performance horses (Reed et al.,
2010b; Couëtil et al., 2016). Wood et al (2005) observed a significant decrease in prevalence of
IAD in horses with increasing age from 2 to 4 years old, with an annual prevalence of 78% in 2year-olds, 50 % in 3-year-olds, and 20% in 4-year-olds; a decrease in the mean duration of IAD
episodes with increases in age was also observed (Wood et al., 2005).
Inflammatory airway disease is typically marked by coughing, nasal discharge, increased
respiratory rate, exercise intolerance and overall poor performance during exercise. While there
can be an increase in respiratory rate, there is no observed increase in expiratory effort, so no
noticeable labored breathing, at rest. The clinical signs are generally mild, so observance of these
symptoms to a more severe extent could be representative of a more severe musculoskeletal or
respiratory disorder such as recurrent airway obstruction (RAO) or exercise-induced pulmonary
hemorrhage (EIPH). Since IAD primarily affects young horses, they should theoretically “grow
out” of the condition; it should not affect their performance career if properly managed. While
some young horses with IAD develop RAO when they are older, this relationship has not been
examined.
Diagnosis can be determined through observation of clinical signs; age of the horse; BAL
to assess neutrophil, eosinophil, mast cell concentrations; endoscopy of the airway looking for
increased mucus in the trachea; differential diagnostic measures should be taken to rule out other
possible diseases of the airway (Mair et al., 2013; Couëtil et al., 2016; Leclere and Lavoie,
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2016). It has been concluded that a BAL is the most reliable diagnosis technique in identification
of inflammation in the peripheral airways (Sprayberry and Robinson, 2015), and is most
commonly used in diagnosis of lower airway conditions to obtain secretions from for cytological
analysis. Generally, it is performed endoscopically where a 120 cm endoscope is passed down to
the level of the bronchi where a lavage is performed (Mair et al., 2013). Cytology of BAL fluid
in IAD horses will typically show mild increases in neutrophils ( > 10% BAL fluid), with
potential increases in eosinophils ( > 5%) and mast cells ( > 5%) (Couëtil et al., 2016).
Environmental management (removal of hay and dusty bedding/soaking hay and feeding
it on the ground), use of bronchodilators to expand the airway, as well as anti-inflammatory
drugs have all been utilized in treatment of IAD (Mair et al., 2013; Couëtil et al., 2016). The
primary goal of treatment is to minimize inhalation of dust and allergens (Sprayberry and
Robinson, 2015). It has been observed that horses consuming hay have higher tracheal neutrophil
concentrations than horses grazing freely out in pasture, so changing from a stable to pasture
environment could aid in decreasing inflammation (Robinson et al., 2006). Bronchodilators and
corticosteroids can be administered both systemically and as an aerosol treatment to reduce
inflammation; however, systemic administration has been concluded to improve lung function
more rapidly. Supplementing a low dust diet with omega-3 fatty acids has also been observed to
modulate the inflammatory response of the disease (Couëtil et al., 2016).
Recurrent Airway Obstruction
Recurrent Airway Obstruction is one of the most common equine respiratory disorders
resulting from obstruction of the small portions of the airway at the level of the bronchioles
(Mair et al., 2013); RAO is commonly referred to as heaves, broken wind, and equine asthma
(Niedzwiedz, 2014; Setlakwe et al., 2014). Characterization of this disorder includes smooth
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muscle contraction in combination with mucus and neutrophil accumulation that subsequently
results in small airway obstruction; this obstruction is reversible. While RAO has been referred
to as equine COPD, it should be noted that the pathophysiology in RAO of horses is different
than the pathophysiology of human COPD; they are not the same condition (Reed et al., 2010b).
The disease is most prevalent around seven to nine years of age, with risk increasing as well as
worsening of airway function as age increases (Reed et al., 2010c; Mair et al., 2013). There is
currently no evidence of breed or gender predisposition since RAO has been observed across all
breeds of horses, ponies, and donkeys; incidences have, however, been observed through specific
breeding lines (Mair et al., 2013; Niedzwiedz, 2014).
Recurrent Airway Obstruction arises from an allergic reaction to pollutants and dust
sourced from feeding hay, bedding, and other potential environmental conditions. This reaction
stimulates an inflammatory response where cytokine production and neutrophil concentrations
increase within the bronchi, leading to subsequent bronchoconstriction (Niedzwiedz, 2014). It
has been observed that collagen content and dysfunction of an elastic fiber network increases in
the airway of heaves-affected horses, which could result in further obstruction (Setlakwe et al.,
2014). Since collagen plays an essential role in the structural component of organs, increases in
collagen can lead to increases in stiffness and decreases in elasticity of the lung, making
expansion more difficult (Muiznieks and Keeley, 2013).
Immediate clinical signs to allergen exposure are not observed in RAO horses; clinical
signs generally present several hours post-exposure (Reed et al., 2010c). A key differentiation
between IAD and RAO is that RAO horses will present with increases in respiratory effort and
lung dysfunction in a resting state, and IAD horses will not (Couëtil et al., 2016). The severity of
the clinical disease can be divided into subclinical, mild clinical, and severely clinical forms
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dependent on the severity of this reaction and response (Mair et al., 2013). Subclinical signs are
minimal, including mucus accumulation, occasional coughing, minimal inflammation, and
exercise intolerance in performance horses. Mild clinical signs include occasional but sporadic
cough, mucus accumulation, minimal nasal discharge, as well as exercise intolerance. Severe
clinical signs are the most noticeable with a chronic cough especially during exercise, increased
respiratory rate, labored breathing during exercise and at rest, dilation of the nostrils
accompanied by discharge, exercise intolerance, and a prolonged recovery period (Mair et al.,
2013).. Due to an increased expiratory effort, hypertrophy of the external abdominal oblique
muscle can occur resulting in what is known as a heave-line. This can also be accompanied by a
severe weight loss from difficulty eating in advanced cases; clinical signs can be used as a
diagnostic measure (Mair et al., 2013).
The primary diagnostic technique for equine RAO include BAL to analyze neutrophil
concentrations, which are generally dramatically increased with RAO (Mair et al., 2013).
Cytology of BAL fluid in RAO horses will typically show severe increases in neutrophils > 25%;
neutrophilic increases up to 80-90% have been observed (Sprayberry and Robinson, 2015;
Couëtil et al., 2016). Other diagnostic techniques include endoscopy of the trachea and bronchi
to look for accumulation of mucus, swelling of the mucosa, and collapse of the airway during
expiration; auscultation of the airway and lungs to detect abnormal airway sounds such as
crackling, wheezing, or even subtle changes in normal breathing pattern; observation of
responses with changes to less dusty feed and environment; as well as responses to drug therapy
(Mair et al., 2013; Niedzwiedz, 2014).
The ideal treatment for RAO horses would be permanent modifications to the
environment and management of the horse such as moving the horse to a pasture environment,
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soaking hay and feeding on ground, increasing ventilation, and removing or watering down dustprone bedding in an attempt to decrease the number of airborne allergens that trigger
inflammation (Reed et al., 2010b; Sprayberry and Robinson, 2015). When making modifications
to feed, it is best to avoid feeding round bale hay, which is high in endotoxin and dust content
(House, 2016). Bronchodilators and corticosteroids are commonly used as temporary solutions to
decrease inflammation and dilate the lower airway to minimize obstruction of airflow (Thomson
and McPherson, 1983; Mair et al., 2013). It has been concluded that inhaled and systemically
administered corticosteroids are beneficial in improving lung function in RAO horses (Couëtil et
al., 2016), and the instillation of platelet-rich plasma in the respiratory tract has been studied as a
possible regenerative therapy to promote healing and reduce inflammation within the airway
(Dzyekanski et al., 2012). A key point to be made is that even with proper treatment, a horse that
had been diagnosed with RAO will always be susceptible to recurrence of the disorder and its
hypersensitive reactions (Reed et al., 2010b).
Exercise-Induced Pulmonary Hemorrhage
Exercise-Induced Pulmonary Hemorrhage is an extremely common condition in
racehorses, such as thoroughbreds, that is a direct result of exercise. Running at high speeds
results in hemorrhage at the level of the lungs, usually in the dorso-caudal regions (Mair et al.,
2013; Couëtil et al., 2016). Studies have concluded that there is an increased risk of EIPH as age
increases as well as throughout the different seasons of the year being higher in the hot and
humid months (Newton and Wood, 2002). It has been theorized that stress failure of the thinwalled pulmonary capillaries, presence of lower airway diseases such as RAO, increases in
pressure at high speeds, and changes in blood viscosity such as during dehydration individually
and cumulatively play a role in the occurrence of EIPH (Mair et al., 2013). It appears that EIPH
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is fundamentally inevitable with the presence of these factors during exercise, so prevention is
not an achievable goal (Marlin, 2015). The rupturing of the capillaries results in pulmonary
hemorrhage which also stimulates an inflammatory response in the airways (Mair et al., 2013). It
has been observed that horses presenting with both IAD and EIPH have a more pronounced
degree of exercise-induced hypoxemia, and subsequently a greater impairment of lung function
(Sanchez et al., 2005).
While clinical signs of exercise-induced pulmonary hemorrhage do exist, a majority of
horses who experience pulmonary hemorrhage do not display noticeable external symptoms.
During exercise, there can sometimes be a reduction in exercise tolerance, respiratory distress
with coughing, as well as an increase in the frequency of swallowing in an attempt to clear blood
from the trachea. While there has been no research to date confirming behavioral changes in
EIPH horses, veterinarians have observed changes in clinical practice such as distress,
uneasiness, reluctance to work, lost stride rhythm and other alterations in behavior. Epistaxis,
presence of blood at the nostrils, can be present but is fairly uncommon and only observed in a
small number of cases (Mair et al., 2013). In a study of 107 thoroughbred horses, 41 displayed
evidence of EIPH, and only one horse had blood at its nostrils (Raphel and Soma, 1982). In
severe cases such as during prolonged strenuous exercise in hot and humid climates, pulmonary
hemorrhage can be fatal (Newton and Wood, 2002; Mair et al., 2013). It has been concluded that
moderate to severe cases of EIPH is associated with increased likelihood of finishing inferior
specifically in Thoroughbred racehorses; however, there is evidence that there is no association
between EIPH grades 1-3 and a shorter racing career (Hinchcliff et al., 2015).
Endoscopy of the airway, tracheal aspiration, and BAL can be used as diagnostic
techniques for EIPH. An endoscopy can be performed approximately one to two hours post
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exercise to identify red blood cells in the large airways (Mair et al., 2013), and is the preferred
method for EIPH diagnosis (Reed et al., 2010b). While a BAL can be used in diagnosing EIPH,
the results should be analyzed cautiously due to its sensitivity red blood cell concentrations. This
technique has been observed to classify EIPH in horses with extremely low grade bleeding that
does not result in poor performance (Sprayberry and Robinson, 2015). It would be best to use in
combination with other diagnostic techniques. Differential diagnostic measures should also be
taken to identify any other possible airway diseases such as inflammation and infection, and
antibiotics can be administered if necessary. Horses should be rested to allow healing in the
airway if EIPH has affected performance or resulted in exercise intolerance (Mair et al., 2013).
In strenuously exercising EIPH horses, Furosemide can be administered to reduce plasma
volume and subsequently decrease blood pressure within the pulmonary capillaries; it does not
prevent EIPH occurrence, but does lessen the severity (Reed et al., 2010b; Sprayberry and
Robinson, 2015).
Lameness
Inflammation does not only occur within the respiratory tract, but also throughout the
musculoskeletal system; inflammation can be both a cause and result of lameness in the horse.
The Merck Veterinary Manual defines lameness as an abnormal stance or gait caused by either a
structural or a functional disorder of the locomotor system which can include joints, cartilage,
ligaments, tendons, as well as skeletal muscle. The general term of lameness can be used to
describe a more extensive problem such as a metabolic disorder or previous trauma (Adams,
2016). Most of the 9.2 million horses in the US are expected to serve some type of athletic role
in service to humans, so if their ability to perform is compromised so is their overall purpose
(Beckstett, 2012). It has been stated that lameness is the primary factor of loss of training in
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young Thoroughbred horses (Lindholm, 1986) and that pain, which can result from
inflammation, is the primary cause of lameness (Adams, 2016). Repetitive stress applied to the
joints and body from speed work, jumping, and extreme hindquarter thrust results in
inflammatory changes to the articular surface and/or the joint capsule which can result in pain,
swelling, and ultimately irreversible damage to the joint (Hotamisligil, 2006). A study examining
barrel racing horses concluded that foot pain in the forelimbs as well as osteoarthritis in the distal
tarsal joints were the most common issues resulting in lameness and decreased performance
(Dabareiner et al., 2005). Veterinarians have observed lameness to be the primary issue in
performance horses.
Pain in the forelimb can be associated with a head nod during active movement as a
diagnostic technique, whereas pain in the hindlimb can be associated with a sacral or pelvic rise.
Fatigue, inflammation, repetitive stress, and inadequate conditioning to exercise and
performance are all potential factors in the onset of lameness. Lameness due to muscle straining
during exercise or musculature abnormalities such as from ER can be addressed with rest and
physiotherapy followed by a recovery period. History of training, age, shoeing, response to antiinflammatory drugs, environment, nutrition, and onset of lameness are all beneficial in diagnosis
of the underlying cause of the lameness. Physical and visual examination of the back, neck, and
limbs during rest and light to moderate exercise are necessary for diagnosis. Hoof testers should
be used for observance of sensitivity from abscesses or bruises. Radiographs can help identify
both acute and chronic changes to bony tissues, and ultrasound can assess any damage to soft
tissues structures such as tendons and ligaments. Neurologic examinations should be performed
if painful or mechanical issues are not observed to examine the possibilities of a neuromuscular
disorder (Adams, 2016). The treatment of lameness will be fully dependent on the underlying
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cause. Some of the most observed lameness in equine includes forefoot lameness, tendonitis, and
osteoarthritis (OA).
Tendonitis
Tendonitis refers to any damage to the tendon as a result of strain or injury. Strain
consists of intrinsic factors such as degradation of the tendon as a result of chronic inflammation,
whereas injury consists of external trauma such as experiencing a blunt force during jumping
(Mair et al., 2013); fatigue has also been observed as a contributing factor to tendon injuries
(O'Sullivan, 2007). Both intrinsic and extrinsic factors can lead to ultimate failure of the tendon
(Sprayberry and Robinson, 2015).
Tendons are primarily composed of type 1 collagen. Tendon cells, tenocytes, form an
extracellular matrix to maintain the alignment of these collagen fibers. Tendons connect muscle
to bone, so they play a key role in maintaining the musculoskeletal relationship that is essential
for movement (Patterson-Kane and Firth, 2009; Sprayberry and Robinson, 2015). Prevalence of
tendon injuries increases with increases in age, as repetitive loading of the tendon causes the
tendon matrix to breakdown faster than the cellular repair can occur (Patterson-Kane and Firth,
2009). An injured tendon undergoes the classic wound healing processes, and the remodeling
phase of the tendon has been observed to last up to 18 months, with decreases in elasticity
(Sprayberry and Robinson, 2015).
Clinical signs of tendon injury included slight increases in skin temperature at the
affected area, swelling, and moderate to severe lameness (Mair et al., 2013). Diagnostic
measures of tendon injuries include palpitation to reveal warmth, swelling, and thickness of the
injured tendon as well as using ultrasonography to identify abnormalities, tears, enlargement,
lesions, and tendinous edema (Mair et al., 2013). For mild tendonitis, ice packs, cold hosing, and
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stall rest can be utilized to limit further damage to the tendon (Mair et al., 2013). For more severe
tendonitis, non-steroidal anti-inflammatory drugs can be administered followed by controlled
exercise, which can be implemented into the treatment program once the inflammation has
subsided to prevent further damage (O'Sullivan, 2007). Regenerative therapies such as stem cells
and platelet-rich plasma as well as physical therapies such as shockwave therapy can also be
utilized to promote healing (Mair et al., 2013).
Osteoarthritis
Osteoarthritis is a progressive deterioration of articular cartilage characterized by
inflammation, joint pain, and decreased range of motion. There can also be negative effects on
the bones, soft tissues, and other structures associated with the joint (Mair et al., 2013;
Sprayberry and Robinson, 2015). The synovial joint consists of a layer of articular cartilage that
provides a smooth surface for joint mobility, and a layer of subchondral bone. The synovial
membrane that surrounds the joint produces the synovial fluid that lubricates the joint; the joint
capsule and the surrounding ligaments provide stability (Sprayberry and Robinson, 2015).
Equine OA can result from repetitive trauma to the synovial joint structures, persistent
inflammation, as well as other joint diseases (Mair et al., 2013). Lasarzik et al (2016) observed
that IL-1 concentrations in the synovial fluid of horses with OA were significantly higher that
horses without OA (Lasarzik et al., 2016). Increased serum concentrations of SAA have also
been observed during inflammatory arthritis induced by intraarticular injection of amphotericin
B in horses (Jacobsen et al., 2006). Both IL-1 and SAA concentrations could be used as
markers of arthritic inflammation.
Clinical signs of OA in equine include observed lameness, pain, decreased movement and
range of motion (Mair et al., 2013), and possible synovial effusion (Sprayberry and Robinson,
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2015). Lameness and flexion exams, analysis of synovial fluid, and radiography are all effective
diagnosis techniques in identifying OA. Synovial fluid is normally clear with a slight yellow hue
with <500 WBCs/L; horses with OA will present high WBC counts up to 1000/L (Sprayberry
and Robinson, 2015). Radiography can reveal new bone formation, narrowed joint space,
subchondral sclerosis, and other abnormalities within the joint (Mair et al., 2013; Sprayberry and
Robinson, 2015). The primary goal of OA treatment is to minimize any pain and further
deterioration of the joint (Sprayberry and Robinson, 2015). Treatment for OA includes physical
therapies such as controlled exercise, swimming, and shock wave therapy; administration of
NSAIDs and nutraceuticals; intraarticular medications such as interleukin-1 receptor agonist
protein (IRAP), PRP, stem cells, and corticosteroids; and surgical management in severe cases
(Mair et al., 2013).
Forefoot lameness
Foot pain in the forelimbs is one of the most common causes of lameness in the horse
(Maliye et al., 2015; Burlington Equine Veterinary Services, 2018). Forefoot lameness can be a
result of anatomical injury or predisposition, physiological dysfunction, improper foot care, and
even strain and injury from exercise. The equine forefoot is made up of numerous bones, soft
tissue structures (tendons, ligaments, bursae, muscles, etc), and nerves. Forefoot bones include
the long pastern bone, short pastern bone, coffin bone (distal phalanx), and navicular bone. These
bones are all susceptible to fracture, infection, inflammation, as well as osteoarthritis. Forefoot
supporting structures include the deep digital flexor tendon, deep digital cushion, collateral
ligament, branches of the suspensory ligaments, sesamoidean ligaments, navicular ligaments,
frog, sensitive and insensitive laminae, joint capsules, and bursae which prevent irritation of the
tendon as it passes over bone. Soft tissue structures are susceptible to inflammation, infection,
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bruising, strain, injury, and laceration (Burlington Equine Veterinary Services, 2018). Some of
the most common conditions resulting in lameness of the forefoot include abscesses, navicular
syndrome, laminitis, bone fractures, deep digital flexor tendonitis, bursitis, osteoarthritis, severe
bruising, and side-bone (Adams, 2016). There are many more conditions that result in forefoot
lameness, this is just naming a few. It has also been observed that a high proportion of horses
with forefoot pain have a primary soft tissue injury (Dyson et al., 2005).
Forefoot lameness can often be accompanied by a compensatory lameness due to
compensatory load redistribution. In a study conducted by Maliye et al (2015), 28 horses were
utilized to quantify the compensatory response to naturally-occurring forelimb lameness. It was
concluded that forelimb lameness does result in a significant compensatory load distribution. In
this specific study the primary compensatory lameness observed was contralateral hindlimb
lameness (Maliye et al., 2015). Other clinical signs of forefoot lameness are more so dependent
on the underlying cause but can include hesitance to bear weight on affected foot, inflammation,
swelling, sensitivity, and increases in digital pulse. Effective diagnostic measures include testing
the hoof for sensitivity, anesthetic blocking, radiography, ultrasonography, and magnetic
resonance imaging (Adams, 2016; Burlington Equine Veterinary Services, 2018). In order to
identify the specific anatomical location causing the forefoot lameness, veterinarians will
generally work “from the ground up” (Burlington Equine Veterinary Services, 2018). Diagnostic
analgesia is utilized in various portions of the forefoot such as the nerves and joints to help
specify and localize the lameness (Schumacher et al., 2004). Treatment protocol will depend on
underlying cause and can consist of rest periods, minimizing mobility; modifications to trimming
and shoeing; NSAID and supplement administration; physical therapies such as shockwave
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therapy, laser therapy, and controlled exercise; and surgical intervention in severe disorders
(Mair et al., 2013; Burlington Equine Veterinary Services, 2018).
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HEADING 7
CONVENTIONAL TREATMENTS OF COMMON AILMENTS IN THE EXERCISED
HORSE
To properly treat common ailments in equine such as inflammation, which severely
reduces performance, there currently is administration of conventional drugs. An example of a
conventional treatment would be Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which are
administered to reduce inflammation and can increase performance in both the musculoskeletal
and respiratory systems (Kallings, 1993). Consequentially, conventional treatments have been
observed to lead to ulcers and susceptibility to secondary illnesses (Dowling, 2002). This chapter
will further discuss the function, benefits, and consequences of conventional treatments.
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Non-steroidal anti-inflammatory drugs are regularly used to alleviate pain from
inflammation, used in musculoskeletal conditions, and for treatment of abdominal pain (Kallings,

Figure 1. NSAID Pathway
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1993; Kallings et al., 2010). These drugs work by blocking the cyclooxygenase (COX) I and II
enzymes, which in return prevents the conversion of arachidonic acid to prostaglandins as well
as the pain and clinical inflammatory responses (Figure 1). The COX-I enzymes are involved in
prostaglandin production during both normal physiological function and injury; COX-II enzymes
are primarily associated with pain and inflammation itself due to their low levels during normal
physiological function and upregulation during injury (Marshall and Blikslager, 2011;
Blikslager, 2015). While blockage of inflammatory prostaglandins aids in reducing pain and
inflammation symptoms, it can also result in adverse side effects such as tissue damage,
ulceration, and colic (Dowling, 2002; Bland, 2015) because the prostaglandins that are inhibited
play a key role in maintaining the mucosal blood flow and barrier of the GI tract. Additionally,
NSAIDs can damage epithelial cells and increase permeability to the GI trait (Mpofu et al.,
2004). Other key prostaglandins include those involved in maintaining renal blood flow when
there is an increased amount of vasoconstrictor substances, such as angiotensin II and antidiuretic hormone, during a state of dehydration. If the production of these prostaglandins is
inhibited when the horse is dehydrated, such as in Heat Stroke, renal blood flow becomes
insufficient and can result in renal toxicity and necrosis (Orme, 1986).
Some of the most commonly used NSAIDs used in horses are phenylbutazone (bute),
flunixin (banamine), and firocoxib (equiox). These drugs have an increased affinity for blood
proteins, so they are well absorbed from the stomach when administered orally (Dowling, 2002).
A study on the effects of flunixin on equine exercise responses reported increased heart rate
specifically during submaximal exercise (8 m/s) with no significant changes in heart rate during
maximal exertion (Kallings et al., 2010). It was theorized that the increase in heart rate during
submaximal exercise was a result of changes in sensitivity of the SA node of the heart to
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sympathetic nervous system stimulation. Kallings et al (2010) also reported increases in plasma
lactate levels as well as stride length (Kallings et al., 2010). Firocoxib products are becoming
extremely popular because they preferentially target the COX-II enzyme which reduces pain and
inflammation, with minimal effects on the COX-I enzymes so prostaglandin production present
during normal physiological function is not inhibited. However, with high doses of firocoxib, its
ability to primarily target the COX-II enzyme is decreased (Blikslager, 2015). Breed, age, and
high doses of NSAIDs predispose horse’s to toxicity (Lees and Higgins, 1985). Since nonsteroidal anti-inflammatory drugs are effective in reducing inflammation, but consequently
increase the risk of ulcers and colic, they should only be administered on a short-term basis and
cautiously to horses with history of gastrointestinal problems.
Corticosteroids (Steroidal Anti-Inflammatory Drugs)
Corticosteroids have powerful anti-inflammatory properties. They work by blocking both
the lipoxygenase and cyclooxygenase enzymes which further prevents the production of

Figure 2. Corticosteroid Pathway
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prostaglandins and inflammatory response (Figure 2). They also increase lipocortin production
which prevents the cleavage of arachidonic acid from the damaged cell walls by inhibiting the
production of phospholipase A2 (Dowling, 2002). Corticosteroids also have immunosuppressive
effects by inhibiting the function of white blood cells as well as production of antibodies, which
can increase the horse’s susceptibility to bacterial, viral, and fungal infections; they have been
associated with abscess formation (Dowling, 2002; Mpofu et al., 2004). Excessive water
consumption and urination are not uncommon since corticosteroids tend to effect body water
regulation. Commonly used corticosteroids in equine are hydrocortisone, methylprednisolone,
prednisolone, and dexamethasone. They can be administered orally, intravenously,
intramuscularly, or via inhalation depending on the underlying condition (Dowling, 2002).
The lipoxygenase enzyme is responsible for the production of leukotrienes D4 and B4,
which have been observed to increase neutrophil production in the lungs and subsequently
induce bronchoconstriction (Marr et al., 1998). Corticosteroids inhibit activity of the
lipoxygenase enzyme, and are commonly used to relieve clinical signs of chronic obstructive
pulmonary disease, acting to reduce inflammation as well as the number of inflammatory cells in
the airway (Barnes and Adcock, 2003; Mair et al., 2013).
Inhalation of corticosteroids for airway inflammation is preferred since it delivers
maximal concentrations more directly to the target site (Mair et al., 2013), it can also be injected
locally to relieve pain in joints and tendons (Dowling, 2002). Systemic absorption of inhaled
corticosteroids does result in suppression of the hypothalamic-pituitary-adrenal axis,
adrenocorticotropic hormone, and subsequently naturally produced cortisol in the body (Rao
Bondugulapati and Rees, 2016). Cortisol plays a key role in homeostasis during exercise;
immune system modulation; the inflammatory process; and mobilization of substrates such as
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fatty acids, amino acids and glucose (Hodgson et al., 2013). The extent of the impairment of
these functions is relative to the quantity of corticosteroids administered (Rao Bondugulapati and
Rees, 2016). There is also an increased risk for laminitis, ulcerations, and toxicity when
administering corticosteroids (Dowling, 2002); however, it has been concluded that oral
administration of prednisolone specifically does not increase the risk for laminitis (Jordan et al.,
2017). Daily administration of dexamethasone been observed to significantly increase blood
lactate concentrations within a 2-day period of administration in equine (Mizen et al., 2017),
which could result in a more rapid onset of fatigue in the exercising horse.
Corticosteroids have been proven to be an effective anti-inflammatory and
bronchodilator; however, their immunosuppressive effects increase susceptibility to infection and
they can have adverse effects on the necessary physiological functions of the performance horse.
Based on these properties, they should not be administered concurrently with immune disorders,
or on a long-term basis to avoid negative effects on equine performance.

-Agonistic Bronchodilators
While corticosteroids can be utilized in reducing airway inflammation, beta-agonists
bronchodilators are the most effective and popular in treating horses with RAO (Mair et al.,
2013; Arroyo et al., 2016). Bronchodilators aid in reducing obstruction by relaxing constricted
smooth muscle portions of the airway, allowing them to dilate and expand. Innervation of betaadrenergic receptors throughout the smooth muscle of the airway leads to relaxation; the most
popular bronchodilators act as beta-adrenergic receptor agonists, targeting these receptors and
stimulating relaxation. Commonly used bronchodilators in equine include epinephrine,
isoproterenol, albuterol, and clenbuterol. Isoproterenol can be administered intravenously,
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slowly, for emergency bronchoconnstriction relief or through inhalation or injection for more
short-term use (Dowling, 2015).
Bronchodilators are used commonly as a short-term treatment of clinical signs of acute
airway inflammation and recurrent airway obstruction (Mair et al., 2013; Arroyo et al., 2016);
however, they do not possess long term effects or treat the underlying disorder. Administration
of albuterol, via inhalation, immediately before exercise can aid in reducing the presence
bronchoconstriction and coughing during the exercise period (Mair et al., 2013); Mazan et al
(2014) observed no adverse effects in equine from albuterol inhalation twice daily for a ten day
period (Mazan et al., 2014); however, a single dose of aerosolized albuterol has been observed to
only last for 1-3 hours (House, 2016). Levalbuterol is a beta-agonist that has been used in the
treatment of human asthma. In a study comparing the effects of levalbuterol compared to
albuterol in the treatment of airway obstruction in horses, it was concluded that there was no
significant difference in the magnitude of improvement in the airway. Doses of levalbuterol,
however, lasted twice as long as those of albuterol suggesting it might be a beneficial alternative
(Arroyo et al., 2016). Previous data has suggested that prolonged administration of clenbuterol
along with training can result in decreased aerobic performance (Kearns and McKeever, 2002).
Thus, long term administration of bronchodilators is not recommended.
Drug Regulations
Currently, Dressage, Jumping, Eventing, Endurance, Driving, Reining, Vaulting, and
Para-Equestrian Dressage are all regulated by the Federation Equstre Internationale (FEI). The
FEI maintains a Code of Conduct to which anyone involved in equestrian sport must adhere to.
Part of this code of conduct is a list of banned substances that are considered to have no
therapeutic use and controlled substances that are considered therapeutic and commonly used to

59
treat equine illness and injury (Sprayberry and Robinson, 2015). Of all the most commonly
administered conventional medicines previously discussed, albuterol, clenbuterol,
dexamethasone, flunixin, fibroxocib, hydrocortisone, methylprednisolone, phenylbutazone,
prednisolone are all listed as controlled FEI substances, however, isoproterenol is listed as a
banned FEI substance as of January 2018 (FEI, 2018a). Improper usage of controlled substances
and any use of banned substances during involvement in these sports can result in fines and legal
contributions up to $16,000 with multiple offenses as well as suspensions up to 2 years (FEI,
2018a).
The Association of Racing Commissioners International (ARCI), located in Lexington,
Kentucky, functions as the regulating body for horse racing in the United States and updates a
list of the Prohibited Substances in Racing in their Uniform Classification Guidelines for Foreign
Substances. The list of Prohibited Substances in Racing categorizes the regulated drugs into 5
classes (1, 2, 3, 4, and 5) based on use of drug and if it would be accepted for use. The
substances are further categorized into 4 penalty classes that differ in penalty severity (A, B, C,
and D). Penalty categories outline the appropriate penalty for usage as well as increases in
offenses (ARCI, 2018b). Epinephrine and isoproterenol are categorized as a class 2 drug with a
class A penalty. Albuterol and clenbuterol are categorized as a class 3 drug with a class B
penatly. Dexmethasone, flunixin, fibroxocib, hydrocortisone, methylprednisolone,
phenylbutazone, and predinisolone are all categorized as a class 4 drug with a class C penalty.
Penalties on flunixin and phenylbutazone are further classified by the specific concentrations
identified in plasma. Along with the penalty classes, violations can also occur through the
stacking of NSAIDs; where more than one NSAID is present in a biological sample (ARCI,
2018b).
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Penalties are dependent upon the category and if it is the 1st, 2nd, or 3rd offense. Use of
substances that are categorized as a class A penalty can result in a 1-year suspension and $10,000
fine for the 1st offense up to a 5-year suspension and $50,000 fine for the 3rd offense. Use of
substances in categorized as a class B penalty can result in a 15-day suspension and $500 fine for
the 1st offense up to a 60-day suspension along with a $2,500 fine for the 3rd offense. Use of
substances categorized as a class C penalty can result in a written warning and $500 fine for the
1st offense up to disqualification and a $2,500 fine for the 3rd offense (ARCI, 2018b).
Along with FEI and ARCI drug regulations, in the United States drugs are also regulated
by the United States Equestrian Federation (USEF). Albuterol, clenbuterol, and epinephrine are
permitted with a properly submitted medication report form. Dexamethasone, fibroxocib,
flunixin, phenylbutazone are permitted but in restricted doses as well as time recommendations
relative to competition (USEF, 2018). Along with specific regulations on these individual drugs,
it is also stated that no medication shall be administered to a horse within 12 hours prior to a
competition, and that only one NSAID is permitted in plasma and/or urine samples that are
collected for testing. Intra-articular administration of local anesthetics, such as those used in
lameness diagnosis, as well as corticosteroid administration is not permitted within 24 hours of
the competition (USEF, 2018). Penalties for improper usage of NSAIDs and dexamethasone can
range from a $750 fine on a first offense to a $3000 fine and 1-month suspension for a third
offense. Penalties for usage of USEF forbidden substances that are FDA approved and possess a
therapeutic use can result in fines up to $12,000 as well as 12-month suspensions (USEF, 2018).
Penalties for usage of USEF forbidden substances that are not FDA approved can result in fines
up to $24,000 and suspensions greater than 2 years (USEF, 2018). The fundamental message is
that equine drug regulations are very serious and should be adhered to.
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Non-steroidal anti-inflammatory drugs, corticosteroids, and bronchodilators are all
conventional treatments currently utilized for exercise related ailments in equine. While they
have been determined to be efficient treatments, they possess proven side effects such as ulcers,
susceptibility to secondary infections, as well as inefficiency or problems from long-term
administration. They are also highly regulated and may not even be an option depending on the
type of sport the horse is involved in. These consequences have led to an increased demand for
regenerative and alternative methods to treat exercise related ailments and increase performance
in equine.
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HEADING 8
REGENERATIVE THERAPIES FOR COMMON AILMENTS IN THE EXERCISED
HORSE
Consequences related to conventional treatments have increased the popularity of
regenerative as well as alternative therapies in equine medicine. Regenerative therapies include
autologous conditioned serum (ACS), platelet-rich plasma (PRP), autologous protein solution
(APS), and stem cells which all work to naturally trigger the healing and repair process within
the body for a variety of musculoskeletal and respiratory conditions.
Autologous Conditioned Serum
As previously discussed, IL-1 concentrations are significantly higher in the synovial
fluid of horses with OA (Lasarzik et al., 2016). Since this protein has been observed to play a
key role in the development of OA, the goal of treatment would be to block the cellular receptor
for IL-1 (Sandoval et al., 2013). This is most commonly done through administration of
Interleukin-1 Receptor Agonist Protein (IRAP). IRAP is primarily administered intra-articular as
a component of autologous conditioned serum (ACS), which can be processed through
commercially available kits; ACS can also be administered for tendon and ligament injuries
(Sprayberry and Robinson, 2015).
It was observed that 4 ACS doses at 7-day intervals resulted in significant improvement
in clinical lameness as well as decreased OA pathology within the synovial membrane in 16
horses with OA-affected joints; there were no observed negative side effects (Frisbie et al.,
2007). A previous study conducted by Frisbie et al (2005) observed a greater degree of joint
repair in OA-affected horses treated with ACS compared to control (Frisbie et al., 2005).
Autologous conditioned serum is prepared by incubating blood filled with medical-grade glass
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beads overnight which stimulates the release of endogenous substances such as IRAP (Bertone et
al., 2014; Sprayberry and Robinson, 2015). Because the processing of ACS requires sterile kits,
incubators, and a centrifuge, it can be a more expensive treatment option.
Platelet Rich Plasma
When injury occurs in the horse, it triggers the activation of platelets circulating in the
blood. Activation stimulates the cellular process of degranulation within the platelets. which
further releases bioactive substances important in healing and regeneration (Sprayberry and
Robinson, 2015). Platelet Rich Plasma (PRP) is an autologous compound, prepared from the
patient’s own blood, that delivers a concentrated dose of platelets, white blood cells, and plasma
directly to the site of injury via injection (Textor, 2011; Rinnovati et al.). A blood sample is
collected from the patient, processed via centrifuge to separate red blood cells from plasma, and
then this platelet rich plasma is injected at the site of injury for tissue regeneration (Textor,
2011). Platelets have been observed as reservoirs of growth factors and anti-inflammatory
cytokines that play an important role in connective tissue healing and cellular regeneration in
both humans and equine (Torricelli et al., 2011; Rinnovati et al., 2016). Activated platelets
secrete numerous growth factors that stimulate angiogenesis and the proliferation of
undifferentiated mesenchymal stem cells, downregulating the pro-inflammatory cytokines IL-1
and TNF-, advancing the musculoskeletal tissue healing process (Torricelli et al., 2011;
Carmona et al., 2018). The administration of PRP has been used as a technique to improve the
quality and speed of healing in damaged areas such as tendons, ligaments, and even in the lungs
(Torricelli et al., 2011).
Most research to date on PRP administration in equine observes the effects within the
musculoskeletal system. Carmona et al (2007) observed significant improvement in joint
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effusion scores after two injections of PRP, and no horses presented with any local or systemic
side effects (Carmona et al., 2007). In a clinical study analyzing the therapeutic effects of PRP
on horses with lameness due to overuse musculoskeletal injuries, specifically either suspensory
ligament desmopathies or superficial flexor tendinopathies, all horses showed a highly
significant mark of improvement in lameness and returned to their pre-injury level of
performance within one year. This specific study concluded that the most effective dosage of
platelet rich plasma should be at a concentrated level of at least 400% of the peripheral blood
platelet count (Torricelli et al., 2011), which is in agreement with previous studies (Marx, 2000).
Waselau et al (2008) has suggested that Standardbred horses with moderate to severe
musculoskeletal disorders had an excellent prognosis for returning to racing when treated with a
single dose of PRP followed by a controlled exercise program (Waselau et al., 2008). In a study
by Zuffova et al (2013) observing PRP administration in Thoroughbred horses with superficial
digital flexor tendiopathies, 100% of horses with mild injury, 56% of horses with moderate
injury, and 64% of horses with severe injury returned to racing post-treatment. It was then
concluded that administration of platelet rich plasma in combination with controlled exercise
positively influenced the healing process of the superficial digital flexor tendinopathies in both
acute and chronic cases (Zuffova et al., 2013) and early treatment of superficial digital flexor
tendinopathies will enhance these effects (Geburek et al., 2016).
While there are veterinarians utilizing PRP in treatment of respiratory conditions such as
EIPH, minimal research has been conducted. In mice, PRP has stimulated lung vascularization
and alveolar regeneration, overall improving pulmonary efficiency and function. Researchers
have concluded that PRP is potentially a beneficial technique in the regeneration of damaged
lung tissue in humans (Mammoto et al., 2016). The limited research on PRP as a respiratory
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therapy has implicated that intrabronchial administration of 20 mL of PRP containing 200% of
whole blood platelet concentration effectively attenuates airway inflammation associated with
IAD (Dzyekanski et al., 2012). As such, this therapy warrants further investigation.
Giraldo et al (2013) observed the effects of breed, sex and age on cellular content and
growth factor release from equine pure-platelet rich plasma. There was an observed significant
difference in whole blood platelet and WBC counts between Argentinean Creole horses and
Colombian Creole horses; platelet and growth factor concentrations in whole blood as well as
platelet rich plasma were also significantly higher in females compared to males (Giraldo et al.,
2013). The same study suggested adapting centrifugation protocols for different breeds since the
size and weight of platelets and WBCs may be different across equine breeds (Giraldo et al.,
2013). When observing the effects of environmental factors such as time of day, hydration,
NSAID therapy, and exercise on platelet concentrations in platelet rich plasma, horses being
administered non-steroidal anti-inflammatory drugs have the most significantly altered
concentrations of platelets; none of the other environmental factors mentioned have been
associated with a significant change (Rinnovati et al., 2016).
Thus far, there has been no research conducted on PRP transfusion; however, there may
be a risk of stimulating an immediate immune-mediated adverse reaction. Most commonly
observed in horses is the febrile nonhemolytic reaction (FNHTR), a systemic inflammatory
response triggered by inflammatory cytokines which can be released by platelets over time
(Sprayberry and Robinson, 2015), such as during a period of storage for transfusion.
Autologous Protein Solution
Both ACS and PRP individually have demonstrated impressive healing qualities on
musculoskeletal injuries in the performance horse. In recent years, autologous protein solution
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(APS) has been introduced as a promising regenerative therapy because of its properties similar
to PRP and ACS in combination. Specifically in humans with OA of the knee, APS has been
observed to improve joint pain within a 1-year period (Kon et al., 2018). It contains a highly
concentrated number of platelets along with the high concentrations of plasma proteins that
produce anti-inflammatory growth factors and cytokines such as IRAP.
Autologous protein solution is created in a two-step process where the patient’s blood is
processed through the APS separator to concentrate the WBCs and platelets in a small amount of
plasma, and then further processed through the APS concentrator (Bertone et al., 2014). The
processing for APS has been observed to preferentially increase the concentration of antiinflammatory cytokines (i.e. IRAP) compared to inflammatory cytokines (i.e. IL-1);
O’Shaughnessey et al (2014) observed a 6.6 fold increase in human APS IRAP concentrations
compared to baseline concentrations (O'Shaughnessey et al., 2014). Similarly, in equine APS has
been observed to have significantly greater concentrations of both IRAP and WBC compared
with normal blood concentrations. In the same study, exercising horses with OA in high motion
joints that received intra-articular injections of APS were observed to have synovial joint fluid
concentrations of IL-1, TNF-, WBCs, and neutrophils all within normal range at 14 days posttreatment; there were no observed negative side-effects with APS injection (Bertone et al., 2014).
To the author’s knowledge, this is the only study analyzing the effects of APS in equine thus far.
The commercial APS treatment in equine is known as “Pro-stride” and can range in price from
$450-800 depending on the number of injections, with on-the-spot processing taking less than an
hour (Hyman, 2015). While more research on the effects of APS in equine is recommended, it
appears to be a suitable regenerative therapy option for joint related lameness.
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Stem Cell Therapy
Stem cell therapy is currently used to promote healing for a variety of musculoskeletal
injuries in equine such as tendinopathies and OA. Stem cells, or progenitor cells, can be defined
as “cells that are capable of self-renewal and can differentiate into specific cell lineages and cell
types” (Sutter, 2007). Primarily in equine medicine, stem cells used in therapy are derived from
mesenchymal tissue and then applied to a site of injury where they differentiate into specific
cells, such as tenocytes, chondrocytes, and osteocytes, and fundamentally produce a woundhealing matrix which is much more beneficial than a scar tissue which is poorly functional
(Sutter, 2007). While there is a sub-population of cells located within growing tissues that is able
to differentiate and replenish cells that are lost during injury, it has not been confirmed that this
sub-population exists in adult tissues, such as the adult tendon. Transplantation of mesenchymal
stem cells (MSC) that do possess these differentiation properties into the site of injury can aid in
necessary regeneration and tissue healing (Richardson et al., 2007).
One of the most common stem cell collection procedures is a bone marrow aspirate,
where bone marrow is collected from the sternum and then injected directly into the site of injury
(Sutter, 2007). Renzi et al (2013) observed no negative side effects or inflammation associated
with the implantation of bone marrow mesenchymal stem cells (Renzi et al., 2013). While MSCs
can be collected from bone marrow, Murata et al (2014) observed synovial fluid to be a potential
source of MSCs used for chondrocyte generation (Murata et al., 2014). The same study showed
that the number of synovial fluid MSCs in horses with diseased joints was significantly increased
compared to synovial fluid MSC concentrations from horses with healthy joints; suggesting that
MSCs may play a role in the repair process of damaged cartilage (Murata et al., 2014).
Interestingly, it has also been observed that dental pulp stem cells (DPSC) derived from wolf
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teeth in Thoroughbred horses possess the potential for self-renewal and differentiation along with
the expression of MSC surface markers. Since they meet the minimal criteria for classification of
MSCs, Ishikawa et al (2017) concluded that eDPSCs may be a new source for stem cell therapy
(Ishikawa et al., 2017).
Autologous conditioned serum, PRP, ACS, and stem cells are all promising regenerative
therapies for both respiratory and musculoskeletal conditions effecting equine performance. At
this time, there are no outlined regulations on the usage of ACS, PRP, APS, or Stem Cell
Therapy (ARCI, 2018a; FEI, 2018b; USEF, 2018). While some regenerative therapies have been
further researched compared to others, they all provide an autologous and natural therapy that
can be used to address underlying conditions compared to the traditional treatments previously
discussed that work to only mask the clinical signs.

69
HEADING 9
ALTERNATIVE THERAPIES FOR COMMON AILMENTS IN THE EXERCISED
HORSE
Along with regenerative therapies, alternative therapies, such as physiotherapies and
supplementation, are used to stimulate and enhance the body’s natural physiological function.
For example, different forms of physical therapy have been observed to stimulate the nervous
system, increase flexibility and mobilization of muscles and joints, reduce inflammation,
increase blood flow, and increase musculoskeletal function (Haussler, 2009; Andris, 2016). As
more research is being conducted and published on these therapies, they are becoming more
accepted in the field of equine veterinary medicine; however, there may still be side-effects from
alternative therapies that have not been observed thus far.
Acupuncture
Acupuncture techniques are used in horses to detect sensitivity, aid in the diagnosis of
lameness, as well as treatment of conditions such as musculoskeletal pain (Le Jeune and Jones,
2014). Acupuncture scanning can be accomplished via palpation of acupuncture points located
along specific pathways and meridians; there are over 100 known acupoints in equine
(Shmalberg and Huisheng, 2009; Le Jeune and Jones, 2014). In a study observing the correlation
of positive acupuncture scans and lameness, 102 performance horses underwent a two-minute
scan of acupuncture points to determine sensitivity and were further evaluated as either lame (51
horses) or sound (51 horses). Acupuncture scanning detected sensitivity in 82.4% of lame horses.
It was concluded that acupuncture scans can be a beneficial component of an overall exam, but
should be accompanied by other diagnostic lameness techniques (Le Jeune and Jones, 2014).
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One of the primary effects of acupuncture techniques is stimulation of the nervous
system, which can increase blood flow and improve physiological function (White and Medicine,
2009). Stimulation of acupuncture points has been observed to aid in inflammation and pain
management through triggering of the pituitary gland to release the adrenocorticotropic hormone
which further stimulates the release of the cortisol, a naturally produced steroidal antiinflammatory, from the adrenal gland (Huisheng et al., 1996). In a study by Martin et al (1987)
observing the effects of acupuncture on chronic back pain in equine, thirteen out of fifteen horses
displayed pain improvement after a mean of eight weekly acupuncture treatments (Martin and
Klide, 1987). Acupuncture techniques are a highly recommended treatment for chronic
musculoskeletal back pain, a common cause of equine lameness (Tangjitjaroen et al., 2009).
In addition to lameness evaluation and treatment, acupuncture techniques can be used to
reduce inflammation and induce a bronchodilator effect throughout the airway in horses
suffering from RAO (Tangjitjaroen et al., 2009). Stimulation of specific acupoints can trigger the
release of endogenous opioids within the CNS which has been observed to result in reduced
expression of pro-inflammatory cytokines TNF- and IL-1 (Yin et al., 2005). Single treatments
of acupuncture in combination with proper environmental management for 10 horses resulted in
improved pulmonary function and parameters such as tidal volume and minute ventilation in
horses with airway inflammation; however, these improvements were not significant (Wilson et
al., 2004). Acupuncture is not considered a long-term treatment of airway inflammation, but
could be beneficial in managing the clinical signs along with proper environmental management
(Tangjitjaroen et al., 2009).
It has also been observed that acupuncture treatment does significantly increase rectal and
skin temperature in horses subjected to a combination of road transport and exercise (Rizzo et
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al., 2017). Current FEI regulations require that equine acupuncture treatments must be carried
out and supervised by a permitted treating veterinarian, and only allows the use of solid needles
(FEI, 2018c), whereas USEF only recommends administration of acupuncture therapy be
performed by a licensed veterinarian (USEF, 2018). More research should be conducted to
confirm the effects of acupuncture stimulation on respiratory and thermoregulatory parameters in
equine.
Chiropractic Therapy
Chiropractic therapy is defined as the application of high-velocity, low-amplitude thrusts
to induce therapeutic effects within articular structures, muscle function, and neurological
reflexes (Haussler, 2009). Fundamentally, these chiropractic manipulations work to realign the
joints of the musculoskeletal system, optimizing nervous system stimulation, blood flow, and
movement in the performance horse. This treatment can result in significant and beneficial
alterations to the kinematics of the spine, increasing overall spinal mobility and flexibility
(Haussler, 2009). The overall goal of chiropractic therapy is to restore normal joint function,
stimulate neurological reflexes, reduce pain, and reduce muscle hypertonicity (Snow, 2013).
Articular neurophysiology, biochemical alterations, pathologic changes within the joint capsule,
and articular degeneration are all basic elements of dysfunction in the joint and/or spine
(Haussler, 2009). Horse owners will seek out chiropractic therapy as a means to treat clinical
signs of lameness including back pain, abnormal movement, stiffness, and loss of performance
(Schultz et al., 2015).
Sullivan et al (2008) observed that out of 40 horses, the 8 horses randomly assigned to
receive chiropractic treatment showed a significantly higher mechanical nociceptive threshold
within the thoracic vertebrae of the spine within 7 days of treatment (Sullivan et al., 2008).
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Chiropractic treatment has also been observed to increase stride length and improve collection in
lesson horses, possibly as a result of increased flexibility and decreased pain in the spinal joints
(Schultz et al., 2015). Significant improvement of symmetric pelvic rotation can also result from
chiropractic joint manipulation, leading to improved gait and performance (Gomez Alvarez et
al., 2008). Gomez Alvarez et al (2008) also observed that in 10 Warmblood horses range of
motion increased directly after chiropractic treatment but decreased within the duration of one
month.
While chiropractic therapy has been concluded to have a beneficial effect on performance
in horses, the effects are generally temporary. In clinical practice, veterinarians have observed
chiropractic therapy to be an extremely beneficial treatment for performance horses of various
disciplines. This form of therapy can be used alone or accompanied by other methods; either way
a valid treatment for joint related musculoskeletal related lameness (Gomez Alvarez et al., 2008).
The United States Equestrian Federation recommendeds that chiropractic therapy be
adiministered either by or under the direct supervision of a veterinarian (USEF, 2018), and FEI
requires that chiropractic may only be carried out by either a permitted equine therapist or a
permitted treating veterinarian (FEI, 2018c).
Massage Therapy
Massage therapy is the manipulation of the skin and underlying soft tissues either
manually, with an instrument, or with a machine for therapeutic purposes; this includes rubbing,
kneading, tapping, and introduction of mechanical vibrations (Haussler, 2009). Therapeutic
massage can relieve muscle tightness, increase muscle compliance, increase joint mobility, and
decrease stiffness within both muscle and joints (Scott and Swenson, 2009). Equine massage
therapy focuses mainly on stress point therapy, trigger point therapy, and myofascial release
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techniques. Trigger point therapy involves applying direct pressure to a hyperirritable area and is
most commonly recognized in sport’s massages in humans. It is common to combine massage
therapy techniques with exercise and other physiotherapies to improve musculoskeletal function
(Buchner and Schildboeck, 2006).
Equine studies focusing on the effects of post-exercise massage on range of motion
observed increased range of motion, increased stride length, and decreased stride frequency
implying a positive effect on the athletic performance horse (Scott and Swenson, 2009).
Additionally, mechanical pressure from massage increases muscle temperature and arteriolar
pressure, fundamentally increasing blood flow. Alterations in heart rate, blood pressure, and
physiological hormones as a result of massage therapy can also induce a relaxation response
during times of stress and anxiety (Scott and Swenson, 2009). A pilot study by Salter et al (2011)
observed significant increases in cutaneous temperatures within five minutes of massage therapy,
suggesting increases in blood flow and perfusion directed to the areas being massaged (Salter et
al., 2011). Increases in blood flow could result in more efficient removal of metabolic
byproducts such as heat, improving performance capabilities. Consistent massage therapy has
also been observed to have positive effects on attempts to reduce stress levels in race horses,
concluding that it is a beneficial technique for equine welfare and performance (Kedzierski et al.,
2017). Some have observed increased manual lymph drainage corresponding with massage in
equine, but there are currently no scientific studies to support this claim. Currently, massage
therapy is considered a non-restricted supportive therapy that may be administered by any person
on horses they are directly responsible for (FEI, 2018c). In general, more research should be
conducted to prove the effects of this technique on equine physiology (Haussler, 2009).

74
Physical Therapy
Mobilization of joints and soft tissue by physical therapists is utilized in assessing quality
and quantity of range of motion in joints for the treatment of musculoskeletal disorders. These
techniques overall aid in rehabilitation of neuromotor control and help to activate spinal reflexes,
increase flexibility, strengthen the musculoskeletal system, and stimulate proprioception.
Physical therapy is primarily used in equine as a means to increase joint mobilization after
removal of a cast or fixture that has caused immobilization (Haussler, 2009), and is the primary
form of therapy for horses competing in competitions that prohibit the use of medications
(Andris, 2016). Some common forms of physical therapy in equine rehabilitation include thermal
therapy, hydrotherapy, rehabilitative exercise, shockwave therapy, laser therapy, and
manipulative therapy.
Thermal therapy consists of both hot and cold techniques. Cold thermal therapy is
utilized in reducing pain during acute injury through techniques such as ice water immersion, ice
surface application, and cold packs. Cold therapy reduces local blood flow, pain, and
inflammation. Heat thermal therapy is applied during chronic injury to enhance tissue stretching
and the healing response primarily in the forms of warm water, hot packs, and therapeutic
ultrasound. Heat therapy increases local blood flow, relaxes muscles, reduces pain, and can
increase joint and tendon mobility (Andris, 2016). Cooling equipment and cooling or heating
pads are considered non-restrictive supportive therapies that can be adniminstered by any
personnel directly responsible for the horse; however, therapeutic ultrasound therapy must be
administered by either a permitted equine therapist or permitted treating veterinarian (FEI,
2018c)
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The use of hot and cold therapy can also be applied to equine hydrotherapy, where water
is utilized to treat injuries in the muscles and joints. Hunt (2001) observed that three to four
weeks of cold water hydrotherapy resolved the fluid component of superficial digital flexor
tendon (SDFT) lesions in 27 horses (Hunt, 2001). All of the non-exercise physical therapy
techniques can be accompanied with controlled exercise, such as hand-walking, treadmill
exercise, and retraining to assist the horse in regaining musculoskeletal tissue strength and
returning to normal performance abilities (Andris, 2016). For example, it has been observed that
administration of hydrotherapy in combination with progressive exercise loading for 16-18
weeks allowed horses to successfully return to racing within a six to eight month period (Hunt,
2001).
Along with basic hydrotherapy, treadmill exercise, both conventional and water, is
becoming increasingly popular in performance horse rehabilitation. It is recommended that
conventional treadmill exercise be utilized for horses with acute SDFT, sacroiliac pain,
suspensory desmitis, and upward fixation of the patella, while water treadmill exercise is
recommended as a post treatment for horses with SDFT, sacroiliac pain, and proximal
suspensory desmitis. Range of motion in pelvic flexion and axial rotation has been observed in
significantly increase during water treadmill exercise at water depths at the level of the fetlock
and higher compared to a control depth of the hoof (Mooij et al., 2013). Stride length was also
observed to increase with increases in pelvic flexion. Mooij et al (2013) concluded that water
depth during treadmill exercise does have an effect on back motion in equine (Mooij et al.,
2013). Both conventional and water treadmill exercise are not recommended for horses with
wounds and deep digital flexor tendinopathies (Nankervis et al., 2017).
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Shockwave therapy has been used in horses with conditions such as tendinitis,
osteoarthritis, and deep muscle pain. Shockwave impulses pass through tissue interfaces leading
to tissue compression, stimulating the healing of bone and soft tissue. Following a two-day rest
period, horses can undergo rehabilitation exercise. It has been observed to reduce inflammation,
increase tissue healing, increase blood vessel proliferation, and reduce pain (Andris, 2016), and
Chen et al (2013) observed that pro-inflammatory cytokine IL-1 was significantly down
regulated in 11 Thoroughbred horses treated with shockwave therapy (Chen et al., 2013). It is
currently recommend that shockwave therapy not be used within 5 days prior to USEF
competition (USEF, 2018), prohibited to administer within 5 days of FEI events (FEI, 2018c),
and ARCI does not permit racing for a minimum of 10 days following a shockwave treatment
(ARCI, 2018a).
Low-level laser therapy is used for treatment of wounds and soft tissue injuries,
osteoarthritis, and in attempts to reduce pain (Andris, 2016). Jann et al (2012) observed that
superficial metacarpal wounds healed significantly faster with the administration of low level
laser therapy compared to control wounds, concluding that low level laser therapy has a positive
effect on wound healing (Jann et al., 2012). Along with wound healing properties, the
combination of both laser therapy and chiropractic techniques has also been observed to reduce
equine musculoskeletal pain more substantially than from the sole practice of one of these
techniques (Andris, 2016). It has been suggested that laser therapy reduces pain and
inflammation via inhibition of the COX II enzyme and reducing inflammatory prostaglandin
production (Saayman et al., 2011). The FEI classifies laser therapy using lasers of classes I to III
as a non-restricted therapy that can be administered by any personnel on horses they are directly
responsible for (FEI, 2018c).
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Manipulative therapy such as range of motion exercises and stretching are utilized to
strengthen muscles, increase flexibility, and reduce pain and muscle discomfort (Andris, 2016).
It has been observed in rats that manipulative therapy in the lumbar region in adult rats results in
a short-term reduction in nociceptive behavior, so fundamentally, a short-term reduction in pain
(Onifer et al., 2015). All in all, physical therapy techniques, used either individually or in
combination, have a great potential for optimizing physiological function in the performance
horse.
Nutraceuticals
Nutraceuticals are considered any natural dietary supplement, typically plant based, that
provide beneficial precursors and catalysts aiding in the prevention and treatment of diseases;
primarily lameness in the horse (Montgomery, 2011). One of the largest issues with
nutraceuticals is that they are not FDA approved and have very little research to prove their
efficacy. While they are being tested more and more, equine research is still very minimal;
proper dosage, side effects, and health benefits for horses is still unknown (Brown, 2009; Bland,
2015). One of the most well-known nutraceutical supplements is Glucosamine, which is
favorably absorbed across the epithelium of the small intestine (Wright, 2001). Glucosamine and
chondroitin sulfate in combination have been studied for their effects in treating equine
musculoskeletal related lameness (Montgomery, 2011). There are many claims that glucosamine
can actually improve motor function in older horses, but a study analyzing the effects of threemonth oral supplementation of glucosamine, at 9.96 g, and chondroitin suflate, at 2.0 g, in 24
horses with a maximum lameness score of 1, concluded there was no sufficient evidence that oral
supplementation results in substantial improvement of locomotor performance in horses (Higler
et al., 2014). Another study observing the effects of oral supplementation of GLC 5500, a
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commercial glucosamine and chondroitin sulfate product, in 50 horses with chronic joint pain
and a lameness score of 2 or greater concluded that oral supplementation of glucosamine and
chondroitin sulfate did aid in reducing the pain associated with lameness, and was not
accompanied by any adverse side effects (Montgomery, 2011). Even with the current research on
glucosamine effects in equine, the quality of some glucosamine products available has been
tested and observed to be substantially different from the claims on their product labels; a
consequence due to the lack of FDA regulations (Oke et al., 2006).
Another up and coming nutraceutical that has been thought to aid in preventing joint
diseases and gastrointestinal diseases associated with inflammation in horses is the herb
turmeric. Curcumin, the active ingredient of turmeric, is known for having anti-inflammatory,
wound healing, and anti-parasitic properties in other species (Oke et al., 2006; El-Bahy and
Bazh, 2015); however, minimal research has been conducted on its efficacy in equine. While
nutraceuticals are gaining popularity in veterinary medicine due to being relatively inexpensive
and having minimal to no demonstrable side effects, the lack of FDA approval for these
substances leads to very little scientific evidence proving or disproving their efficacy for the
conditions that they claim to address. Glucosamine and curcumin have not been listed on the
previously mentioned lists of substance regulation (ARCI, 2018b; FEI, 2018a; USEF, 2018). Due
to the minimal amount of research that has been conducted observing effects of nutraceuticals
specifically in equine, it is difficult to properly assess the benefits and consequences of this type
of supplementation (Brown, 2009).
Other Supplements
A common supplement in equine feed is Vitamin E, which contains antioxidant
properties that aid in the prevention of cellular damage and oxidative stress. Intense exercise can
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lead to oxidative stress in the performance horse, meaning they might benefit from increased
vitamin E supplementation. Studies have observed decreased levels of beta-carotene, necessary
for Vitamin A synthesis, with increased levels of vitamin E (Williams and Carlucci, 2006).
Vitamin A serves a key role in vision, immune system function, normal growth, as well as
maintenance of epithelial cells (Hinchcliff et al., 2013). Supplementation of antioxidants such as
sodium selenite and ascorbic acid have been observed to significantly improve the clinical signs
of chronic lower airway disease. These improvements have been associated with subsequent
increases of selenium, vitamin C, and vitamin E in the epithelial lining fluid of the airway,
improvements in lung function, and reduction in oxidative damage. It has been suggested
selenium supplementation could be an effective treatment of airway inflammation such as during
chronic obstructive pulmonary disease and inflammatory airway disease (Youssef et al., 2013).
Currently. Vitamins A, C, E are all categorized by ARCI as non-classified substances that only
affect the physiology of the horse through improvement of nutrition or to treat/prevent
infections; supplementation is not regulated (ARCI, 2018b).
Amino acid supplementation has been utilized in aging horses to minimize the quantity of
muscle mass loss. In aging, lightly exercised horses it was observed that supplementation of the
amino acids lysine and threonine improved the maintenance and reduced overall muscle mass
loss (Graham-Thiers and Kronfeld, 2005). While these benefits have been recorded, however, the
ideal requirement of amino acid supplementation has not been defined (Graham-Thiers and
Kronfeld, 2005).
Ribose supplementation was hypothesized to decrease ammonia and lactic acid
accumulation during exercise, prolonging the onset of fatigue and improving overall
performance. In a study by Kavazis et al. (2004) analyzing the effects of ribose supplementation

80
8 horses were provided 0.15 g of either glucose or ribose supplement per kilogram of body
weight twice daily prior to participating in a standard exercise test. After the standard exercise
test, blood was collected, and ammonia, lactic acid, and glucose levels were analyzed. After a
two week period, it was concluded that the ribose supplementation did not influence the above
factors, and does not affect overall anaerobic exercise capacity (Kavazis et al., 2004). Betaine
supplementation has also been observed for its effects associated with lactate concentrations
(Warren et al., 1999). When supplementing 80 milligrams of betaine per kilogram of body
weight for 14 days, there was no observed changes in lactate concentrations prior to exercise.
However, lactate concentrations were observed to significantly decrease during the recovery
period post exercise in untrained horses compared to baseline levels. It was concluded that
betaine supplementation does influence post exercise lactate metabolism, specifically in the
untrained horse (Warren et al., 1999). Amino acids, ribose, and betaine have not been listed on
the previously mentioned lists of substance regulation (ARCI, 2018b; FEI, 2018a; USEF, 2018).

81
HEADING 10
CONCLUSION
As discussed, some of the primary exercise related ailments that reduce equine
performance originate within the respiratory and musculoskeletal systems. Inflammation and
fatigue alone and on a minimal basis are relatively inevitable, but without proper treatment can
lead to more severe conditions such as Exhausted Horse Syndrome, Exertional Rhabdomyolysis,
and Recurrent Airway Obstruction. Through the evaluation of these different traditional
treatments and alternative and regenerative therapies for common exercise related ailments in the
performance horse, it is evident that there is currently no perfect solution. Traditional treatments
can be used effectively on a short-term basis for reducing inflammation and inducing
bronchodilation. However, any individual that administers these medications must be aware of
their potential consequences such as ulcers and increased susceptibility to secondary infections.
Regenerative therapies are becoming more popular as more research is being conducted and are
an autologous solution that stimulates natural healing processes. While the alternative treatments
are still relatively new to the field of equine medicine, they have shown very promising results
when used in conjunction and sometimes in place of the traditional treatments. These
regenerative and alternative therapies both focus to enhance the horse’s natural physiological
processes, and so far, minimal side effects have been observed. Further research on the efficacy
of some of these therapies and supplements would be extremely beneficial in the education of the
equine industry.
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